US20140355852A1 - Methods of Predicting Musculoskeletal Disease - Google Patents

Methods of Predicting Musculoskeletal Disease Download PDF

Info

Publication number
US20140355852A1
US20140355852A1 US14/462,760 US201414462760A US2014355852A1 US 20140355852 A1 US20140355852 A1 US 20140355852A1 US 201414462760 A US201414462760 A US 201414462760A US 2014355852 A1 US2014355852 A1 US 2014355852A1
Authority
US
United States
Prior art keywords
bone
image
data
parameters
cartilage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/462,760
Inventor
Siau-Way Liew
Daniel Steines
Philipp Lang
Rene Vargas-Voracek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Conformis Imatx Inc
Original Assignee
Imatx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/665,725 external-priority patent/US20040106868A1/en
Application filed by Imatx Inc filed Critical Imatx Inc
Priority to US14/462,760 priority Critical patent/US20140355852A1/en
Publication of US20140355852A1 publication Critical patent/US20140355852A1/en
Assigned to IMATX, INC. reassignment IMATX, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: VARGAS-VORACEK, RENE
Assigned to IMATX, INC. reassignment IMATX, INC. MERGER AND CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: IMAGING THERAPEUTICS, INC., IMATX, INC.
Assigned to IMAGING THERAPEUTICS, INC. reassignment IMAGING THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LIEW, SIAU-WAY, STEINES, DANIEL, LANG, PHILIPP
Priority to US15/809,366 priority patent/US20180330499A1/en
Priority to US16/289,054 priority patent/US20190370961A1/en
Assigned to INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT reassignment INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CONFORMIS CARES LLC, CONFORMIS, INC., IMATX, INC.
Assigned to INNOVATUS LIFE SCIENCES LENDING FUND I, LP reassignment INNOVATUS LIFE SCIENCES LENDING FUND I, LP RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CONFORMIS CARES LLC, CONFORMIS, INC., IMATX, INC.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00Image analysis
    • G06T7/0002Inspection of images, e.g. flaw detection
    • G06T7/0012Biomedical image inspection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/48Diagnostic techniques
    • A61B6/482Diagnostic techniques involving multiple energy imaging
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/52Devices using data or image processing specially adapted for radiation diagnosis
    • A61B6/5211Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
    • A61B6/5217Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data extracting a diagnostic or physiological parameter from medical diagnostic data
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/58Testing, adjusting or calibrating apparatus or devices for radiation diagnosis
    • A61B6/582Calibration
    • A61B6/583Calibration using calibration phantoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/52Devices using data or image processing specially adapted for diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/5215Devices using data or image processing specially adapted for diagnosis using ultrasonic, sonic or infrasonic waves involving processing of medical diagnostic data
    • A61B8/5223Devices using data or image processing specially adapted for diagnosis using ultrasonic, sonic or infrasonic waves involving processing of medical diagnostic data for extracting a diagnostic or physiological parameter from medical diagnostic data
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T5/00Image enhancement or restoration
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/50Clinical applications
    • A61B6/505Clinical applications involving diagnosis of bone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/08Detecting organic movements or changes, e.g. tumours, cysts, swellings
    • A61B8/0875Detecting organic movements or changes, e.g. tumours, cysts, swellings for diagnosis of bone
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2200/00Indexing scheme for image data processing or generation, in general
    • G06T2200/04Indexing scheme for image data processing or generation, in general involving 3D image data
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00Indexing scheme for image analysis or image enhancement
    • G06T2207/20Special algorithmic details
    • G06T2207/20092Interactive image processing based on input by user
    • G06T2207/20104Interactive definition of region of interest [ROI]
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00Indexing scheme for image analysis or image enhancement
    • G06T2207/30Subject of image; Context of image processing
    • G06T2207/30004Biomedical image processing
    • G06T2207/30008Bone

Definitions

  • This invention relates to using imaging methods for diagnosis, prognostication, monitoring and management of disease, particularly where that disease affects the musculoskeletal system.
  • This invention identifies novel imaging markers for use in diagnosis, prognostication, monitoring and management of disease, including musculoskeletal disease.
  • Osteoporosis and osteoarthritis are among the most common conditions to affect the musculoskeletal system, as well as frequent causes of locomotor pain and disability. Osteoporosis can occur in both human and animal subjects (e.g. horses). Osteoporosis (OP) and osteoarthritis (OA) occur in a substantial portion of the human population over the age of fifty. The National Osteoporosis Foundation estimates that as many as 44 million Americans are affected by osteoporosis and low bone mass. In 1997 the estimated cost for osteoporosis related fractures was $13 billion. That figure increased to $17 billion in 2002 and is projected to increase to $210-240 billion by 2040. Currently it is expected that one in two women over the age of 50 will suffer an osteoporosis-related fracture.
  • Imaging techniques are important diagnostic tools, particularly for bone related conditions such as OP and OA.
  • DXA dual x-ray absorptiometry
  • QCT quantitative computed tomography
  • PDXA peripheral DXA
  • PQCT peripheral QCT
  • DXA of the spine and hip has established itself as the most widely used method of measuring BMD. Tothill, P. and D. W. Pye, (1992) Br J Radiol 65:807-813.
  • the fundamental principle behind DXA is the measurement of the transmission through the body of x-rays of 2 different photon energy levels. Because of the dependence of the attenuation coefficient on the atomic number and photon energy, measurement of the transmission factors at 2 energy levels enables the area densities (i.e., the mass per unit projected area) of 2 different types of tissue to be inferred. In DXA scans, these are taken to be bone mineral (hydroxyapatite) and soft tissue, respectively. However, it is widely recognized that the accuracy of DXA scans is limited by the variable composition of soft tissue.
  • Quantitative computed tomography is usually applied to measure the trabecular bone in the vertebral bodies.
  • QCT studies are generally performed using a single kV setting (single-energy QCT), when the principal source of error is the variable composition of the bone marrow.
  • a dual-kV scan dual-energy QCT is also possible. This reduces the accuracy errors but at the price of poorer precision and higher radiation dose.
  • QCT are very expensive and the use of such equipment is currently limited to few research centers.
  • Quantitative ultrasound is a technique for measuring the peripheral skeleton. Njeh et al. (1997) Osteoporosis Int 7:7-22; Njeh et al. Quantitative Ultrasound: Assessment of Osteoporosis and Bone Status. 1999, London, England: Martin Dunitz. There is a wide variety of equipment available, with most devices using the heel as the measurement site. A sonographic pulse passing through bone is strongly attenuated as the signal is scattered and absorbed by trabeculae. Attenuation increases linearly with frequency, and the slope of the relationship is referred to as broadband ultrasonic attenuation (BUA; units: dB/MHz).
  • BOA broadband ultrasonic attenuation
  • BUA is reduced in patients with osteoporosis because there are fewer trabeculae in the calcaneus to attenuate the signal.
  • most QUS systems also measure the speed of sound (SOS) in the heel by dividing the distance between the sonographic transducers by the propagation time (units: m/s). SOS values are reduced in patients with osteoporosis because with the loss of mineralized bone, the elastic modulus of the bone is decreased.
  • SOS speed of sound
  • Radiographic absorptiometry is a technique that was developed many years ago for assessing bone density in the hand, but the technique has recently attracted renewed interest. Gluer et al. (1997) Semin Nucl Med 27:229-247. With this technique, BMD is measured in the phalanges.
  • the principal disadvantage of RA of the hand is the relative lack of high turnover trabecular bone. For this reason, RA of the hand has limited sensitivity in detecting osteoporosis and is not very useful for monitoring therapy-induced changes.
  • Peripheral x-ray absorptiometry methods such as those described above are substantially cheaper than DXA and QCT with system prices ranging between $15,000 and $35,000.
  • epidemiologic studies have shown that the discriminatory ability of peripheral BMD measurements to predict spine and hip fractures is lower than when spine and hip BMD measurements are used. Cummings et al. (1993) Lancet 341:72-75; Marshall et al. (1996) Br Med J 312:1254-1259. The main reason for this is the lack of trabecular bone at the measurement sites used with these techniques.
  • the present invention discloses novel methods and techniques for predicting musculoskeletal disease, particularly methods and compositions that result in the ability to obtain accurate predictions about disease based on bone mineral density and/or bone structure information obtained from images (e.g., radiographic images) and data.
  • the invention discloses a method for analyzing at least one of bone mineral density, bone structure and surrounding tissue.
  • the method typically comprises: (a) obtaining an image of a subject; (b) locating a region of interest on the image; (c) obtaining data from the region of interest; and (d) deriving data selected from the group of qualitative and quantitative from the image data obtained at step c.
  • a system for predicting a disease. Any of these systems can include the steps of: (a) obtaining image data of a subject; (b) obtaining data from the image data wherein the data obtained is at least one of quantitative and qualitative data; and (c) comparing the at least one of quantitative and qualitative data in step b to at least one of: a database of at least one of quantitative and qualitative data obtained from a group of subjects; at least one of quantitative and qualitative data obtained from the subject; and at least one of a quantitative and qualitative data obtained from the subject at time Tn.
  • micro-structural, macroanatomical and/or biomechanical parameters may be, for example, one or more of the measurements/parameters shown in Tables 1, 2 and/or 3.
  • one or more micro-structural parameters and one or more macro-anatomical parameters are combined.
  • one or more micro-structural parameters and one or more biomechanical parameters are combined.
  • one or more macroanatomical parameters and one or more biomechanical parameters are combined.
  • one or more macroanatomical parameters, one or more micro-structural parameters and one or more biomechanical parameters are combined.
  • one or more macroanatomical parameters, one or more micro-structural parameters and one or more biomechanical parameters are combined.
  • the comparing may be comprise univariate, bivariate and/or multivariate statistical analysis of one or more of the parameters.
  • the methods may further comprise comparing said parameters to data derived from a reference database of known disease parameters.
  • the parameters are determined from an image obtained from the subject.
  • the image comprises one or more regions of bone (e.g., patella, femur, tibia, fibula, pelvis, spine, etc).
  • the image may be automatically or manually divided into two or more regions of interest.
  • the image may be, for example, an x-ray image, a CT scan, an MRI or the like and optionally includes one or more calibration phantoms.
  • the predicting includes performing univariate, bivariate or multivariate statistical analysis of the analyzed data and referencing the statistical analysis values to a fracture risk model.
  • Fracture risk models can comprise, for example, data derived from a reference database of known fracture loads with their corresponding values of macro-anatomical, micro-anatomical parameters, and/or clinical risk factors.
  • the invention includes a method of determining the effect of a candidate agent on a subject's prognosis for musculoskeletal disease comprising: predicting a first risk of musculoskeletal disease in subject according to any of the predictive methods described herein; administering a candidate agent to the subject; predicting a second risk of the musculoskeletal disease in the subject according to any of the predictive methods described herein; and comparing the first and second risks, thereby determining the effect of the candidate on the subject's prognosis for the disease.
  • the candidate agent can be administered to the subject in any modality, for example, by injection (intramuscular, subcutaneous, intravenous), by oral administration (e.g., ingestion), topical administration, mucosal administration or the like.
  • the candidate agent may be a small molecule, a pharmaceutical, a biopharmaceutical, an agropharmaceuticals and/or combinations thereof.
  • the invention includes a kit that is provided for aiding in the prediction of musculoskeletal disease (e.g., fracture risk).
  • the kit typically comprises a software program that uses information obtained from an image to predict the risk or disease (e.g., fracture).
  • the kit can also include a database of measurements for comparison purposes. Additionally, the kit can include a subset of a database of measurements for comparisons.
  • additional steps can be provided. Such additional steps include, for example, enhancing image data.
  • Suitable subjects for these steps include for example mammals, humans and horses.
  • Suitable anatomical regions of subjects include, for example, dental, spine, hip, knee and bone core x-rays.
  • a variety of systems can be employed to practice the inventions.
  • at least one of the steps of any of the methods is performed on a first computer.
  • the first computer and the second computer are typically connected. Suitable connections include, for example, a peer to peer network, direct link, intranet, and internet.
  • any or all of the steps of the inventions disclosed can be repeated one or more times in series or in parallel with or without the repetition of other steps in the various methods. This includes, for example repeating the step of locating a region of interest, or obtaining image data.
  • Data can also be converted from 2D to 3D to 4D and back; or from 2D to 4D.
  • Data conversion can occur at multiple points of processing the information. For example, data conversion can occur before or after pattern evaluation and/or analysis.
  • Any data obtained, extracted or generated under any of the methods can be compared to a database, a subset of a database, or data previously obtained, extracted or generated from the subject.
  • known fracture load can be determined for a variety of subjects and some or all of this database can be used to predict fracture risk by correlating one or more macro-anatomical or structural parameters (Tables 1, 2 and/or 3) with data from a reference database of fracture load for age, sex, race, height and weight matched individuals.
  • the present invention provides methods that allow for the analysis of bone mineral density, bone and/or cartilage structure and morphology and/or surrounding tissue from images including electronic images and, accordingly, allows for the evaluation of the effect(s) of an agent (or agents) on bone and/or cartilage.
  • an effect on bone and/or cartilage can occur in agents intended to have an effect, such as a therapeutic effect, on bone and/or cartilage as well as agents intended to primarily effect other tissues in the body but which have a secondary, or tangential, effect on bone and/or cartilage.
  • the images e. g., x-ray images
  • the images can be, for example, dental, hip, spine or other radiographs and can be taken from any mammal.
  • the images can be in electronic format.
  • the invention includes a method to derive quantitative information on bone structure and/or bone mineral density from an image comprising (a) obtaining an image, wherein the image optionally includes an external standard for determining bone density and/or structure; and (b) analyzing the image obtained in step (a) to derive quantitative information on bone structure.
  • the image is taken of a region of interest (ROI). Suitable ROI include, for example, a hip radiograph or a dental x-ray obtained on dental x-ray film, including the mandible, maxilla or one or more teeth.
  • the image is obtained digitally, for example using a selenium detector system, a silicon detector system or a computed radiography system.
  • the image can be digitized from film, or another suitable source, for analysis.
  • a method is included where one or more candidate agents can be tested for its effects on bone.
  • the effect can be a primary effect or a secondary effect.
  • images obtained from the subject can be evaluated prior to administration of a candidate agent to predict the risk of disease in the absence of the agent.
  • an electronic image of the same portion of a bone of the subject can be obtained and analyzed as described herein to predict the risk of musculoskeletal disease.
  • the risk of disease prior to administration of the candidate agent and after administration can then be compared to determine if the agent had any effect on disease prognosis.
  • Information on bone structure can relate to a variety of parameters, including the parameters shown in Table 1, Table 2 and Table 3, infra.
  • the images or data may also be compared to a database of images or data (e.g., “known” images or data).
  • the candidate agent can, for example, be molecules, proteins, peptides, naturally occurring substances, chemically synthesized substances, or combinations and cocktails thereof.
  • an agent includes one or more drugs.
  • the agent can be evaluated for the ability to effect bone diseases such as the risk of bone fracture (e.g., osteoporotic fracture).
  • the analysis can comprise using one or more computer programs (or units). Additionally, the analysis can comprise identifying one or more regions of interest (ROI) in the image, either prior to, concurrently or after analyzing the image, e.g. for information on bone mineral density and/or bone structure.
  • the bone density information can be, for example, areas of highest, lowest or median density.
  • Bone structural information can be, for example, one or more of the parameters shown in Table 1, Table 2 and Table 3.
  • the various analyses can be performed concurrently or in series. Further, when using two or more indices each of the indices can be weighted equally or differently, or combinations thereof where more than two indices are employed. Additionally, any of these methods can also include analyzing the image for bone mineral density information using any of the methods described herein.
  • correction factors can be programmed into a computer unit.
  • the computer unit can be the same one that performs the analysis of the image or can be a different unit.
  • the correction factors account for the variation in soft-tissue thickness in individual subjects.
  • FIGS. 1A AND B are block diagrams showing the steps for extracting data from an image and then deriving quantitative and/or qualitative data from the image.
  • FIGS. 2A-C are diagrams showing an image taken of a region of anatomical interest further illustrating possible locations of regions of interest for analysis.
  • FIGS. 3A-J illustrate various abnormalities that might occur including, for example, cartilage defects, bone marrow edema, subchondral sclerosis, osteophytes and cysts.
  • FIGS. 4A AND B are block diagrams of the method of FIG. 1A showing that the steps can be repeated.
  • FIGS. 5A-E are block diagrams illustrating steps involved in evaluating patterns in an image of a region of interest.
  • FIG. 6A-E are block diagrams illustrating steps involved in deriving quantitative and qualitative data from an image in conjunction with administering candidate molecules or drugs for evaluation.
  • FIGS. 7A-D are block diagrams illustrating steps involved in comparing derived quantitative and qualitative information to a database or to information obtained at a previous time.
  • FIGS. 8A-D are block diagrams illustrating steps involved in comparing converting an image to a pattern of normal and diseased tissue
  • FIG. 9 is a diagram showing the use one or more devices in the process of developing a degeneration pattern and using a database for degeneration patterns.
  • FIG. 10 depicts regions of interest (ROIs) analyzed in Example 1.
  • FIG. 11 depicts results of biomechanical testing of 15 cadaveric hips and femurs.
  • FIG. 12A-B are reproductions of x-ray images depicting an exemplary induced fracture in cadaveric femur resulting from biomechanical testing and load.
  • FIG. 13 is a graph depicting correlation of DXA femoral neck bone mineral density (BMD) versus biochemical fracture load as evaluated in 15 fresh cadaveric hip samples.
  • BMD DXA femoral neck bone mineral density
  • FIG. 14A-C are graphs depicting correlation of bone structure versus mechanical fracture load.
  • FIG. 14A depicts correlation of maximum marrow spacing v. fracture load.
  • FIG. 14B depicts correlation of maximum marrow spacing (log) v. fracture load.
  • FIG. 14C depicts correlation of percentage of trabecular area v. fracture load.
  • FIG. 15A-C are graphs depicting correlation of macro-anatomical features versus biomechanical fracture load.
  • FIG. 15A depicts correlation of cortical thickness v. fracture load.
  • FIG. 15B depicts correlation of hip axis length (HAL) V. fracture load.
  • FIG. 15C depicts correlation of cortical thickness (standard deviation) versus fracture load.
  • FIG. 16 is a graph depicting multivariate analysis using a combination of bone structural and macro-anatomical parameters and shows the correlation of predicted fracture load to actual fracture load.
  • the first step is to locate a part of the body of a subject, for example in a human body, for study 98 .
  • the part of the body located for study is the region of anatomical interest (RAI).
  • RAI anatomical interest
  • a determination is made to, for example, take an image or a series of images of the body at a particular location, e.g. hip, dental, spine, etc.
  • Images include, for example, conventional x-ray images, x-ray tomosynthesis, ultrasound (including A-scan, B-scan and C-scan) computed tomography (CT scan), magnetic resonance imaging (MRI), optical coherence tomography, single photon emission tomography (SPECT), and positron emission tomography, or such other imaging tools that a person of skill in the art would find useful in practicing the invention.
  • CT scan computed tomography
  • MRI magnetic resonance imaging
  • SPECT single photon emission tomography
  • positron emission tomography or such other imaging tools that a person of skill in the art would find useful in practicing the invention.
  • ROI region of interest
  • Algorithms can be used to automatically place regions of interest in a particular image. See, e.g., Example 1 describing automatic placement of ROIs in femurs.
  • Image data is extracted from the image 102 .
  • quantitative and/or qualitative data is extracted from the image data 120 .
  • Each step of locating a part of the body for study 98 , optionally locating a region of interest 100 , obtaining image data 102 , and deriving data 120 can be repeated one or more times 99 , 101 , 103 , 121 , respectively, as desired.
  • image data can be optionally enhanced 104 by applying image processing techniques, such as noise filtering or diffusion filtering, to facilitate further analysis. Similar to the process shown in FIG. 1A , locating a part of the body for study 98 , optionally locating a region of interest 100 , obtaining image data 102 , enhancing image data 104 , and deriving data 120 , can be repeated one or more times 99 , 101 , 103 , 105 , 121 , respectively, as desired.
  • image processing techniques such as noise filtering or diffusion filtering
  • the parameters and measurements shown in Table 1 are provided for illustration purposes. It will be apparent that the terms micro-structural parameters, micro-architecture, micro-anatomic structure, micro-structural and trabecular architecture may be used interchangably.
  • other parameters and measurements, ratios, derived values or indices can be used to extract quantitative and/or qualitative information about the ROI without departing from the scope of the invention.
  • the parameter measured can be the same parameter or a different parameter without departing from the scope of the invention.
  • data from different ROIs can be combined or compared as desired.
  • Additional measurements can be performed that are selected based on the anatomical structure to be studied as described below.
  • TBPf (P1 ⁇ P2)/(A1 ⁇ A2) where P1 and A1 are the perimeter length and trabecular bone area before dilation and P2 and A2 corresponding values after a single pixel dilation, measure of connectivity) Connected skeleton count or Trees (T) Node count (N) Segment count (S) Node-to-node segment count (NN) Node-to-free-end segment count (NF) Node-to-node segment length (NNL) Node-to-free-end segment length (NFL) Free-end-to-free-end segment length (FFL) Node-to-node total struts length
  • the data can be manipulated to assess the severity of the disease and to determine disease staging (e.g., mild, moderate, severe or a numerical value or index).
  • the information can also be used to monitor progression of the disease and/or the efficacy of any interventional steps that have been taken. Finally, the information can be used to predict the progression of the disease or to randomize patient groups in clinical trials.
  • FIG. 2A illustrates an image 200 taken of an RAI, shown as 202 .
  • a single region of interest (ROI) 210 has been identified within the image.
  • the ROI 210 can take up the entire image 200 , or nearly the entire image.
  • more than one ROI can be identified in an image.
  • a first ROI 220 is depicted in one region of the image 200
  • a second ROI 222 is depicted within the image. In this instance, neither of these ROI overlap or abut.
  • the number of ROI identified in an image 200 is not limited to the two depicted.
  • FIG. 2C another embodiment showing two ROI for illustration purposes is shown.
  • the first ROI 230 and the second ROI 232 are partially overlapping.
  • any or all of the ROI can be organized such that it does not overlap, it abuts without overlapping, it overlaps partially, it overlaps completely (for example where a first ROI is located completely within a second identified ROI), and combinations thereof.
  • the number of ROI per image 200 can range from one (ROI 1 ) to n (ROI n ) where n is the number of ROI to be analyzed.
  • Bone density, microarchitecture, macro-anatomic and/or biomechanical (e.g. derived using finite element modeling) analyses can be applied within a region of predefined size and shape and position. This region of interest can also be referred to as a “window.” Processing can be applied repeatedly within the window at different positions of the image. For example, a field of sampling points can be generated and the analysis performed at these points. The results of the analyses for each parameter can be stored in a matrix space, e.g., where its position corresponds to the position of the sampling point where the analysis occurred, thereby forming a map of the spatial distribution of the parameter (a parameter map).
  • the sampling field can have regular intervals or irregular intervals with varying density across the image.
  • the window can have variable size and shape, for example to account for different patient size or anatomy.
  • the amount of overlap between the windows can be determined, for example, using the interval or density of the sampling points (and resolution of the parameter maps).
  • the density of sampling points is set higher in regions where higher resolution is desired and set lower where moderate resolution is sufficient, in order to improve processing efficiency.
  • the size and shape of the window would determine the local specificity of the parameter. Window size is preferably set such that it encloses most of the structure being measured. Oversized windows are generally avoided to help ensure that local specificity is not lost.
  • the shape of the window can be varied to have the same orientation and/or geometry of the local structure being measured to minimize the amount of structure clipping and to maximize local specificity.
  • both 2D and/or 3D windows can be used, as well as combinations thereof, depending on the nature of the image and data to be acquired.
  • bone density, microarchitecture, macro-anatomic and/or biomechanical (e.g. derived using finite element modeling) analyses can be applied within a region of predefined size and shape and position.
  • the region is generally selected to include most, or all, of the anatomic region under investigation and, preferably, the parameters can be assessed on a pixel-by-pixel basis (e.g., in the case of 2D or 3D images) or a voxel-by-voxel basis in the case of cross-sectional or volumetric images (e.g., 3D images obtained using MR and/or CT).
  • the analysis can be applied to clusters of pixels or voxels wherein the size of the clusters is typically selected to represent a compromise between spatial resolution and processing speed. Each type of analysis can yield a parameter map.
  • Parameter maps can be based on measurement of one or more parameters in the image or window; however, parameter maps can also be derived using statistical methods. In one embodiment, such statistical comparisons can include comparison of data to a reference population, e.g. using a z-score or a T-score. Thus, parameter maps can include a display of z-scores or T-scores.
  • measurements relating to the site to be measured can also be taken.
  • measurements can be directed to dental, spine, hip, knee or bone cores. Examples of suitable site specific measurements are shown in Table 2.
  • analysis can also include one or more additional techniques include, for example, Hough transform, mean pixel intensity analysis, variance of pixel intensity analysis, soft tissue analysis and the like. See, e.g., co-owned International Application WO 02/30283.
  • Calibrated density typically refers to the measurement of intensity values of features in images converted to its actual material density or expressed as the density of a reference material whose density is known.
  • the reference material can be metal, polymer, plastics, bone, cartilage, etc., and can be part of the object being imaged or a calibration phantom placed in the imaging field of view during image acquisition.
  • Extracted structures typically refer to simplified or amplified representations of features derived from images.
  • An example would be binary images of trabecular patterns generated by background subtraction and thresholding.
  • Another example would be binary images of cortical bone generated by applying an edge filter and thresholding.
  • the binary images can be superimposed on gray level images to generate gray level patterns of structure of interest.
  • Distance transform typically refers to an operation applied on binary images where maps representing distances of each 0 pixel to the nearest 1 pixel are generated. Distances can be calculated by the Euclidian magnitude, city-block distance, La Place distance or chessboard distance.
  • Distance transform of extracted structures typically refer to distance transform operation applied to the binary images of extracted structures, such as those discussed above with respect to calibrated density.
  • Skeleton of extracted structures typically refer to a binary image of 1 pixel wide patterns, representing the centerline of extracted structures. It is generated by applying a skeletonization or medial transform operation, by mathematical morphology or other methods, on an image of extracted structures.
  • Skeleton segments typically are derived from skeleton of extracted structures by performing pixel neighborhood analysis on each skeleton pixel. This analysis classifies each skeleton pixel as a node pixel or a skeleton segment pixel.
  • a node pixel has more than 2 pixels in its 8-neighborhood.
  • a skeleton segment is a chain of skeleton segment pixels continuously 8-connected. Two skeleton segments are separated by at least one node pixel.
  • Watershed segmentation as it is commonly known to a person of skill in the art, typically is applied to gray level images to characterize gray level continuity of a structure of interest.
  • the statistics of dimensions of segments generated by the process are, for example, those listed in Table 3 above. As will be appreciated by those of skill in the art, however, other processes can be used without departing from the scope of the invention.
  • FIG. 3A a cross-section of a cartilage defect is shown 300 .
  • the cross-hatched zone 302 corresponds to an area where there is cartilage loss.
  • FIG. 3B is a top view of the cartilage defect shown in FIG. 3A .
  • FIG. 3C illustrates the depth of a cartilage defect 310 in a first cross-section dimension with a dashed line illustrating a projected location of the original cartilage surface 312 .
  • FIG. 3D illustrated the depth of the cartilage 320 along with the width of the cartilage defect 322 . These two values can be compared to determine a ratio of cartilage depth to cartilage defect width.
  • FIG. 3E shows the depth of the cartilage defect 310 along with the depth of the cartilage 320 .
  • a dashed line is provided illustrating a projected location for the original cartilage surface 312 . Similar to the measurements made above, ratios between the various measurements can be calculated.
  • FIG. 3F an area of bone marrow edema is shown on the femur 330 and the tibia 332 .
  • the shaded area of edema can be measured on a T2-weighted MRI scan. Alternatively, the area can be measured on one or more slices. These measurements can then be extended along the entire joint using multiple slices or a 3D acquisition. From these measurements volume can be determined or derived.
  • FIG. 3G shows an area of subchondral sclerosis in the acetabulum 340 and the femur 342 .
  • the sclerosis can be measured on, for example, a T1 or T2-weighted MRI scan or on a CT scan.
  • the area can be measured on one or more slices. Thereafter the measurement can be extended along the entire joint using multiple slices or a 3D acquisition. From these values a volume can be derived of the subchondral sclerosis.
  • a single sclerosis has been shown on each surface. However, a person of skill in the art will appreciate that more than one sclerosis can occur on a single joint surface.
  • FIG. 3H shows osteophytes on the femur 350 and the tibia 352 .
  • the osteophytes are shown as cross-hatched areas. Similar to the sclerosis shown in FIG. 3G , the osteophytes can be measured on, for example, a T1 or T2-weighted MRI scan or on a CT scan. The area can be measured on one or more slices. Thereafter the measurement can be extended along the entire joint using multiple slices or a 3D acquisition. From these values a volume can be derived of the osteophytes. Additionally, a single osteophyte 354 or osteophyte groups 356 can be included in any measurement. Persons of skill in the art will appreciate that groups can be taken from a single joint surface or from opposing joint surfaces, as shown, without departing from the scope of the invention.
  • FIG. 31 an area of subchondral cysts 360 , 362 , 364 is shown. Similar to the sclerosis shown in FIG. 3G , the cysts can be measured on, for example, a T1 or T2-weighted MRI scan or on a CT scan. The area can be measured on one or more slices. Thereafter the measurement can be extended along the entire joint using multiple slices or a 3D acquisition. From these values a volume can be derived of the cysts. Additionally, single cysts 366 or groups of cysts 366 ′ can be included in any measurement. Persons of skill in the art will appreciate that groups can be taken from a single joint surface, as shown, or from opposing joint surfaces without departing from the scope of the invention.
  • FIG. 3J illustrates an area of torn meniscal tissue (cross-hatched) 372 , 374 as seen from the top 370 and in cross-section 371 .
  • the torn meniscal tissue can be measured on, for example, a T1 or T2-weighted MRI scan or on a CT scan. The area can be measured on one or more slices. Thereafter the measurement can be extended along the entire joint using multiple slices or a 3D acquisition. From these values a volume can be derived of the tear. Ratios such as surface or volume of torn to normal meniscal tissue can be derived as well as ratios of surface of torn meniscus to surface of opposing articulating surface.
  • the process of optionally locating a ROI 100 , extracting image data from the ROI 102 , and deriving quantitative and/or qualitative image data from the extracted image data 120 can be repeated 122 .
  • the process of locating a ROI 100 can be repeated 124 .
  • these steps can be repeated one or more times in any appropriate sequence, as desired, to obtain a sufficient amount of quantitative and/or qualitative data on the ROI or to separately extract or evaluate parameters.
  • the ROI used can be the same ROI as used in the first process or a newly identified ROI in the image.
  • the steps of locating a region of interest 100 , obtaining image data 102 , and deriving quantitative and/or qualitative image data can be repeated one or more times, as desired, 101 , 103 , 121 , respectively.
  • the additional step of locating a part of the body for study 98 can be performed prior to locating a region of interest 100 without departing from the invention. Additionally that step can be repeated 99 .
  • FIG. 4B illustrates the process shown in FIG. 4A with the additional step enhancing image data 104 .
  • the step of enhancing image data 104 can be repeated one or more times 105 , as desired.
  • the process of enhancing image data 104 can be repeated 126 one or more times as desired.
  • FIG. 5A a process is shown whereby a region of interest is optionally located 100 .
  • the step of locating a part of the body for study 98 can be performed prior to locating a region of interest 100 without departing from the invention. Additionally that step can be repeated 99 .
  • the extracted image data can then be converted to a 2D pattern 130 , a 3D pattern 132 or a 4D pattern 133 , for example including velocity or time, to facilitate data analyses.
  • the images are evaluated for patterns 140 .
  • images can be converted from 2D to 3D 131 , or from 3D to 4D 131 ′, if desired.
  • 3D to 4D 131 ′ images can be converted from 2D to 3D 131 , or from 3D to 4D 131 ′, if desired.
  • the conversion step is optional and the process can proceed directly from extracting image data from the ROI 102 to evaluating the data pattern 140 directly 134 .
  • Evaluating the data for patterns includes, for example, performing the measurements described in Table 1 ,Table 2 or Table 3, above.
  • the steps of locating the region of interest 100 , obtaining image data 102 , and evaluating patterns 141 can be performed once or a plurality of times, 101 , 103 , 141 , respectively at any stage of the process. As will be appreciated by those of skill in the art, the steps can be repeated. For example, following an evaluation of patterns 140 , additional image data can be obtained 135 , or another region of interest can be located 137 . These steps can be repeated as often as desired, in any combination desirable to achieve the data analysis desired.
  • FIG. 5B illustrates an alternative process to that shown in FIG. 5A which 5 A THAT includes the step of enhancing image data 104 prior to converting an image or image data to a 2D 130 , 3D 132 , or 4D 133 pattern.
  • the process of enhancing image data 104 can be repeated 105 if desired.
  • FIG. 5C illustrates an alternative embodiment to the process shown in FIG. 5B .
  • the step of enhancing image data 104 occurs after converting an image or image data to a 2D 130 , 3D 132 , or 4D 133 pattern.
  • the process of enhancing image data 104 can be repeated 105 if desired.
  • FIG. 5D illustrates an alternative process to that shown in FIG. 5A .
  • the image is then converted to a 2D pattern 130 , 3D pattern 132 or 4D pattern 133 .
  • the region of interest 100 is optionally located within the image after conversion to a 2D, 3D or 4D image and data is then extracted 102 . Patterns are then evaluated in the extracted image data 140 .
  • the conversion step is optional. Further, if desired, images can be converted between 2D, 3D 131 and 4D 131 ′ if desired.
  • some or all the processes can be repeated one or more times as desired. For example, locating a part of the body for study 98 , locating a region of interest 100 , obtaining image data 102 , and evaluating patterns 140 , can be repeated one or more times if desired, 99 , 101 , 103 , 141 , respectively. Again steps can be repeated. For example, following an evaluation of patterns 140 , additional image data can be obtained 135 , or another region of interest can be located 137 and/or another portion of the body can be located for study 139 . These steps can be repeated as often as desired, in any combination desirable to achieve the data analysis desired.
  • FIG. 5E illustrates an alternative process to that shown in FIG. 5D .
  • image data can be enhanced 104 .
  • the step of enhancing image data can occur prior to conversion 143 , prior to locating a region of interest 145 , prior to obtaining image data 102 , or prior to evaluating patterns 149 .
  • some or all the processes can be repeated one or more times as desired, including the process of enhancing image data 104 , which is shown as 105 .
  • the method also comprises obtaining an image of a bone or a joint, optionally converting the image to a two-dimensional or three-dimensional or four-dimensional pattern, and evaluating the amount or the degree of normal, diseased or abnormal tissue or the degree of degeneration in a region or a volume of interest using one or more of the parameters specified in Table 1, Table 2 and/or Table 3.
  • information can be derived that is useful for diagnosing one or more conditions or for staging, or determining, the severity of a condition. This information can also be useful for determining the prognosis of a patient, for example with osteoporosis or arthritis.
  • the change for example in a region or volume of interest, can be determined which then facilitates the evaluation of appropriate steps to take for treatment. Moreover, if the subject is already receiving therapy or if therapy is initiated after time T 1 , it is possible to monitor the efficacy of treatment. By performing the method at subsequent times, T 2 -T n . additional data ca be acquired that facilitate predicting the progression of the disease as well as the efficacy of any interventional steps that have been taken. As will be appreciated by those of skill in the art, subsequent measurements can be taken at regular time intervals or irregular time intervals, or combinations thereof.
  • T 1 it can be desirable to perform the analysis at T 1 with an initial follow-up, T 2 , measurement taken one month later.
  • the pattern of one month follow-up measurements could be performed for a year (12 one-month intervals) with subsequent follow-ups performed at 6 month intervals and then 12 month intervals.
  • three initial measurements could be at one month, followed by a single six month follow up which is then followed again by one or more one month follow-ups prior to commencing 12 month follow ups.
  • the combinations of regular and irregular intervals are endless, and are not discussed further to avoid obscuring the invention.
  • one or more of the parameters listed in Tables 1, 2 and 3 can be measured.
  • the measurements can be analyzed separately or the data can be combined, for example using statistical methods such as linear regression modeling or correlation. Actual and predicted measurements can be compared and correlated. See, also, Example 1.
  • the method for assessing the condition of a bone or joint in a subject can be fully automated such that the measurements of one or more of the parameters specified in Table 1, Table 2 or Table 3 are done automatically without intervention.
  • the automatic assessment then can include the steps of diagnosis, staging, prognostication or monitoring the disease or diseases, or to monitor therapy.
  • the fully automated measurement is, for example, possible with image processing techniques such as segmentation and registration. This process can include, for example, seed growing, thresholding, atlas and model based segmentation methods, live wire approaches, active and/or deformable contour approaches, contour tracking, texture based segmentation methods, rigid and non-rigid surface or volume registration, for example based on mutual information or other similarity measures.
  • image processing techniques such as segmentation and registration.
  • This process can include, for example, seed growing, thresholding, atlas and model based segmentation methods, live wire approaches, active and/or deformable contour approaches, contour tracking, texture based segmentation methods, rigid and non-rigid surface or volume registration, for example
  • the method of assessing the condition of a bone or joint in a subject can be semi-automated such that the measurements of one or more of the parameters, such as those specified in Table 1, are performed semi-automatically, i.e., with intervention.
  • the semi-automatic assessment then allows for human interaction and, for example, quality control, and utilizing the measurement of said parameter(s) to diagnose, stage, prognosticate or monitor a disease or to monitor a therapy.
  • the semi-automated measurement is, for example, possible with image processing techniques such as segmentation and registration.
  • seed growing, thresholding, atlas and model based segmentation methods live wire approaches, active and/or deformable contour approaches, contour tracking, texture based segmentation methods, rigid and non-rigid surface or volume registration, for example base on mutual information or other similarity measures.
  • a process is shown whereby the user locates a ROI 100 , extracts image data from the ROI 102 , and then derives quantitative and/or qualitative image data from the extracted image data 120 , as shown above with respect to FIG. 1 .
  • a candidate agent is administered to the patient 150 .
  • the candidate agent can be any agent the effects of which are to be studied.
  • Agents can include any substance administered or ingested by a subject, for example, molecules, pharmaceuticals, biopharmaceuticals, agropharmaceuticals, or combinations thereof, including cocktails, that are thought to affect the quantitative and/or qualitative parameters that can be measured in a region of interest.
  • agents are not limited to those intended to treat disease that affects the musculoskeletal system but this invention is intended to embrace any and all agents regardless of the intended treatment site.
  • appropriate agents are any agents whereby an effect can be detected via imaging.
  • the steps of locating a region of interest 100 , obtaining image data 102 , obtaining quantitative and/or qualitative data from image data 120 , and administering a candidate agent 150 can be repeated one or more times as desired, 101 , 103 , 121 , 151 , respectively.
  • FIG. 6B shows the additional step of enhancing image data 104 , which can also be optionally repeated 105 as often as desired.
  • these steps can be repeated one or more times 152 to determine the effect of the candidate agent.
  • the step of repeating can occur at the stage of locating a region of interest 152 as shown in FIG. 6B or it can occur at the stage obtaining image data 153 or obtaining quantitative and/or qualitative data from image data 154 as shown in FIG. 6D .
  • FIG. 6E shows the additional step of enhancing image data 104 , which can optionally be repeated 105 , as desired.
  • some or all the processes shown in FIGS. 6A-E can be repeated one or more times as desired. For example, locating a region of interest 100 , obtaining image data 102 , enhancing image data 104 , obtaining quantitative and/or qualitative data 120 , evaluating patterns 140 , and administering candidate agent 150 can be repeated one or more times if desired, 101 , 103 , 105 , 121 , 141 , 151 respectively.
  • an image is taken prior to administering the candidate agent.
  • progress is determined over time by evaluating the change in parameters from extracted image to extracted image.
  • FIG. 7A the process is shown whereby the candidate agent is administered first 150 . Thereafter a region of interest is located in an image taken 100 and image data is extracted 102 . Once the image data is extracted, quantitative and/or qualitative data is extracted from the image data 120 . In this scenario, because the candidate agent is administered first, the derived quantitative and/or qualitative data derived is compared to a database 160 or a subset of the database, which database that, includes data for subjects having similar tracked parameters. As shown in FIG. 7B following the step of obtaining image data, the image data can be enhanced 104 . This process can optionally be repeated 105 , as desired.
  • the derived quantitative and/or qualitative information can be compared to an image taken at T1 162 , or any other time, if such image is available.
  • the step of enhancing image data 104 can follow the step of obtaining image data 102 . Again, the process can be repeated 105 , as desired.
  • some or all the processes illustrated in FIGS. 7A-D can be repeated one or more times as desired. For example, locating a region of interest 100 , obtaining image data 102 , enhancing image data 104 , obtaining quantitative and/or qualitative data 120 , administering candidate agent 150 , comparing quantitative and/or qualitative information to a database 160 , comparing quantitative and/or qualitative information to an image taken at a prior time, such as T 1 , 162 , monitoring therapy 170 , monitoring disease progress 172 , predicting disease course 174 can be repeated one or more times if desired, 101 , 103 , 105 , 121 , 151 , 161 , 163 , 171 , 173 , 175 respectively. Each of these steps can be repeated in one or more loops as shown in FIG. 7B , 176 , 177 , 178 , 179 , 180 , as desired or appropriate to enhance data collection.
  • the image can be transmitted 180 .
  • Transmission can be to another computer in the network or via the World Wide Web to another network.
  • the image is converted to a pattern of normal and diseased tissue 190 .
  • Normal tissue includes the undamaged tissue located in the body part selected for study.
  • Diseased tissue includes damaged tissue located in the body part selected for study.
  • Diseased tissue can also include, or refer to, a lack of normal tissue in the body part selected for study. For example, damaged or missing cartilage would be considered diseased tissue.
  • FIG. 8B illustrates the process shown in FIG. 8A with the additional step of enhancing image data 104 . As will be appreciated by those of skill in the art, this process can be repeated 105 as desired.
  • FIG. 8C the step of transmitting the image 180 illustrated in FIG. 8A is optional and need not be practiced under the invention.
  • the image can also be analyzed prior to converting the image to a pattern of normal and diseased.
  • FIG. 8D illustrates the process shown in FIG. 8C with the additional step of enhancing image data 104 that is optionally repeated 105 , as desired.
  • FIGS. 8A-D can be repeated one or more times as desired. For example, locating a region of interest 100 , obtaining image data 102 , enhancing image data 104 , transmitting an image 180 , converting the image to a pattern of normal and diseased 190 , analyzing the converted image 200 , can be repeated one or more times if desired, 101 , 103 , 105 , 181 , 191 , 201 respectively.
  • FIG. 9 shows two devices 900 , 920 that are connected.
  • Either the first or second device can develop a degeneration pattern from an image of a region of interest 905 .
  • either device can house a database for generating additional patterns or measurements 915 .
  • the first and second devices can communicate with each other in the process of analyzing an image, developing a degeneration pattern from a region of interest in the image, and creating a dataset of patterns or measurements or comparing the degeneration pattern to a database of patterns or measurements.
  • all processes can be performed on one or more devices, as desired or necessary.
  • the electronically generated, or digitized image or portions of the image can be electronically transferred from a transferring device to a receiving device located distant from the transferring device; receiving the transferred image at the distant location; converting the transferred image to a pattern of normal or diseased or abnormal tissue using one or more of the parameters specified in Table 1, Table 2 or Table 3; and optionally transmitting the pattern to a site for analysis.
  • the transferring device and receiving device can be located within the same room or the same building.
  • the devices can be on a peer-to-peer network, or an intranet. Alternatively, the devices can be separated by large distances and the information can be transferred by any suitable means of data transfer, including the World Wide Web and ftp protocols.
  • the method can comprise electronically transferring an electronically-generated image or portions of an image of a bone or a joint from a transferring device to a receiving device located distant from the transferring device; receiving the transferred image at the distant location; converting the transferred image to a degeneration pattern or a pattern of normal or diseased or abnormal tissue using one or more of the parameters specified in Table 1, Table 2 or Table 3; and optionally transmitting the degeneration pattern or the pattern of normal or diseased or abnormal tissue to a site for analysis.
  • FIG. 10 is a schematic depiction of an image of a femur showing various ROIs that were analyzed to predict fracture risk based on assessment of one or more parameters shown in Tables 1, 2 and 3.
  • a fracture risk model correlated with fracture load may be developed using univariate, bivariate and/or multivariate statistical analysis of these parameters and is stored in this database.
  • a fracture risk model may include information that is used to estimate fracture risk from parameters shown in Tables 1, 2 and 3.
  • fracture risk model is the coefficients of a multivariate linear model derived from multivariate linear regression of these parameters (Tables 1,2,3, age, sex, weight, etc.) with fracture load.
  • fracture risk models can be derived using other methods such as artificial neural networks and be represented by other forms such as the coefficients of artificial neural networks. Patient fracture risk can then be determined from measurements obtain from bone images by referencing to this database.
  • FIG. 11 is a schematic depiction of biomechanical testing of an intact femur. As shown, cross-sectional images may be taken throughout testing to determine at what load force a fracture occurs.
  • FIG. 12B is a reproduction of an x-ray image depicting an example of an induced fracture in a fresh cadaveric femur.
  • FIG. 13 is a graph depicting linear regression analysis of DXA bone mineral density correlated to fracture load. Correlations of individual parameters to fracture load are comparable to DXA ( FIGS. 14 and 15 ). However, when multiple structural parameters are combined, the prediction of load at which fracture will occur is more accurate. ( FIG. 16 ). Thus, the analyses of images as described herein can be used to accurately predict musculoskeletal disease such as fracture risk.
  • kits for aiding in assessing the condition of a bone or a joint of a subject comprises a software program, which when installed and executed on a computer reads a degeneration pattern or a pattern of normal or diseased or abnormal tissue derived using one or more of the parameters specified in Table 1, Table 2 or Table 3 presented in a standard graphics format and produces a computer readout.
  • the kit can further include a database of measurements for use in calibrating or diagnosing the subject.
  • One or more databases can be provided to enable the user to compare the results achieved for a specific subject against, for example, a wide variety of subjects, or a small subset of subjects having characteristics similar to the subject being studied.
  • a system includes (a) a device for electronically transferring a degeneration pattern or a pattern of normal, diseased or abnormal tissue for the bone or the joint to a receiving device located distant from the transferring device; (b) a device for receiving said pattern at the remote location; (c) a database accessible at the remote location for generating additional patterns or measurements for the bone or the joint of the human wherein the database includes a collection of subject patterns or data, for example of human bones or joints, which patterns or data are organized and can be accessed by reference to characteristics such as type of joint, gender, age, height, weight, bone size, type of movement, and distance of movement; (d) optionally a device for transmitting the correlated pattern back to the source of the degeneration pattern or pattern of normal, diseased or abnormal tissue.
  • the methods and systems described herein make use of collections of data sets of measurement values, for example measurements of bone structure and/or bone mineral density from images (e.g., x-ray images). Records can be formulated in spreadsheet-like format, for example including data attributes such as date of image (x-ray), patient age, sex, weight, current medications, geographic location, etc.
  • the database formulations can further comprise the calculation of derived or calculated data points from one or more acquired data points, typically using the parameters listed in Tables 1, 2 and 3 or combinations thereof.
  • a variety of derived data points can be useful in providing information about individuals or groups during subsequent database manipulation, and are therefore typically included during database formulation. Derived data points include, but are not limited to the following: (1) maximum value, e.g.
  • bone mineral density determined for a selected region of bone or joint or in multiple samples from the same or different subjects
  • minimum value e.g. bone mineral density, determined for a selected region of bone or joint or in multiple samples from the same or different subjects
  • mean value e.g. bone mineral density, determined for a selected region of bone or joint or in multiple samples from the same or different subjects
  • (4) the number of measurements that are abnormally high or low determined by comparing a given measurement data point with a selected value; and the like.
  • Other derived data points include, but are not limited to the following: (1) maximum value of a selected bone structure parameter, determined for a selected region of bone or in multiple samples from the same or different subjects; (2) minimum value of a selected bone structure parameter, determined for a selected region of bone or in multiple samples from the same or different subjects; (3) mean value of a selected bone structure parameter, determined for a selected region of bone or in multiple samples from the same or different subjects; (4) the number of bone structure measurements that are abnormally high or low, determined by comparing a given measurement data point with a selected value; and the like.
  • Other derived data points will be apparent to persons of ordinary skill in the art in light of the teachings of the present specification.
  • the amount of available data and data derived from (or arrived at through analysis of) the original data provides an unprecedented amount of information that is very relevant to management of bone-related diseases such as osteoporosis. For example, by examining subjects over time, the efficacy of medications can be assessed.
  • Measurements and derived data points are collected and calculated, respectively, and can be associated with one or more data attributes to form a database.
  • the amount of available data and data derived from (or arrived at through analysis of) the original data provide provides an unprecedented amount of information that is very relevant to management of musculoskeletal-related diseases such as osteoporosis or arthritis. For example, by examining subjects over time, the efficacy of medications can be assessed.
  • Data attributes can be automatically input with the electronic image and can include, for example, chronological information (e.g., DATE and TIME). Other such attributes can include, but are not limited to, the type of imager used, scanning information, digitizing information and the like. Alternatively, data attributes can be input by the subject and/or operator, for example subject identifiers, i.e. characteristics associated with a particular subject.
  • chronological information e.g., DATE and TIME
  • Other such attributes can include, but are not limited to, the type of imager used, scanning information, digitizing information and the like.
  • data attributes can be input by the subject and/or operator, for example subject identifiers, i.e. characteristics associated with a particular subject.
  • identifiers include but are not limited to the following: (1) a subject code (e.g., a numeric or alpha-numeric sequence); (2) demographic information such as race, gender and age; (3) physical characteristics such as weight, height and body mass index (BMI); (4) selected aspects of the subject's medical history (e.g., disease states or conditions, etc.); and (5) disease-associated characteristics such as the type of bone disorder, if any; the type of medication used by the subject.
  • a subject code e.g., a numeric or alpha-numeric sequence
  • demographic information such as race, gender and age
  • physical characteristics such as weight, height and body mass index (BMI)
  • BMI body mass index
  • selected aspects of the subject's medical history e.g., disease states or conditions, etc.
  • disease-associated characteristics such as the type of bone disorder, if any; the type of medication used by the subject.
  • each data point would typically be identified with the particular subject, as well as the demographic, etc. characteristic of that subject.
  • data e.g., bone structural information or bone mineral density information or articular information
  • reference databases can be used to aid analysis of any given subject's image, for example, by comparing the information obtained from the subject to the reference database.
  • the information obtained from the normal control subjects will be averaged or otherwise statistically manipulated to provide a range of “normal” measurements. Suitable statistical manipulations and/or evaluations will be apparent to those of skill in the art in view of the teachings herein.
  • the comparison of the subject's information to the reference database can be used to determine if the subject's bone information falls outside the normal range found in the reference database or is statistically significantly different from a normal control.
  • Data obtained from images, as described above, can be manipulated, for example, using a variety of statistical analyses to produce useful information.
  • Databases can be created or generated from the data collected for an individual, or for a group of individuals, over a defined period of time (e.g., days, months or years), from derived data, and from data attributes.
  • data can be aggregated, sorted, selected, sifted, clustered and segregated by means of the attributes associated with the data points.
  • Relationships in various data can be directly queried and/or the data analyzed by statistical methods to evaluate the information obtained from manipulating the database.
  • a distribution curve can be established for a selected data set, and the mean, median and mode calculated therefor. Further, data spread characteristics, e.g., variability, quartiles, and standard deviations can be calculated.
  • correlation coefficients useful methods for doing so include, but are not limited to: Pearson Product Moment Correlation and Spearman Rank Correlation. Analysis of variance permits testing of differences among sample groups to determine whether a selected variable has a discernible effect on the parameter being measured.
  • Non-parametric tests can be used as a means of testing whether variations between empirical data and experimental expectancies are attributable to chance or to the variable or variables being examined. These include the Chi Square test, the Chi Square Goodness of Fit, the 2 ⁇ 2 Contingency Table, the Sign Test and the Phi Correlation Coefficient. Other tests include z-scores, T-scores or lifetime risk for arthritis, cartilage loss or osteoporotic fracture.
  • Such tools and analysis include, but are not limited to, cluster analysis, factor analysis, decision trees, neural networks, rule induction, data driven modeling, and data visualization. Some of the more complex methods of data mining techniques are used to discover relationships that are more empirical and data-driven, as opposed to theory driven, relationships.
  • the data is preferably stored and manipulated using one or more computer programs or computer systems. These systems will typically have data storage capability (e.g., disk drives, tape storage, optical disks, etc.). Further, the computer systems can be networked or can be stand-alone systems. If networked, the computer system would be able to transfer data to any device connected to the networked computer system for example a medical doctor or medical care facility using standard e-mail software, a central database using database query and update software (e.g., a data warehouse of data points, derived data, and data attributes obtained from a large number of subjects). Alternatively, a user could access from a doctor's office or medical facility, using any computer system with Internet access, to review historical data that can be useful for determining treatment.
  • database query and update software e.g., a data warehouse of data points, derived data, and data attributes obtained from a large number of subjects.
  • the application includes the executable code required to generate database language statements, for example, SQL statements. Such executables typically include embedded SQL statements.
  • the application further includes a configuration file that contains pointers and addresses to the various software entities that are located on the database server in addition to the different external and internal databases that are accessed in response to a user request.
  • the configuration file also directs requests for database server resources to the appropriate hardware, as can be necessary if the database server is distributed over two or more different computers.
  • one or more of the parameters specified in Table 1, Table and Table 3 can be used at an initial time point T 1 to assess the severity of a bone disease such as osteoporosis or arthritis.
  • the patient can then serve as their own control at a later time point T 2 , when a subsequent measurement using one or more of the same parameters used at T 1 is repeated.
  • one or more of the parameters specified in Table 1, Table 2 and Table 3 may be used to identify lead compounds during drug discovery. For example, different compounds can be tested in animal studies and the lead compounds with regard to highest therapeutic efficacy and lowest toxicity, e.g. to the bone or the cartilage, can be identified. Similar studies can be performed in human subjects, e. g. FDA phase I, II or III trials.
  • one or more of the parameters specified in Table 1, Table 2 and Table 3 can be used to establish optimal dosing of a new compound. It will be appreciated also that one or more of the parameters specified in Table 1, Table 2 and Table 3 can be used to compare a new drug against one or more established drugs or a placebo. The patient can then serve as their own control at a later time point T 2 ,
  • Standardization of Hip radiographs Density and magnification calibration on the x-ray radiographs was achieved using a calibration phantom.
  • the reference orientation of the hip x-rays was the average orientation of the femoral shaft.
  • a global gray level thresholding using bi-modal histogram segmentation algorithm(s) was performed on the hip images and a binary image of the proximal femur was generated.
  • Edge-detection analysis was also performed on the hip x-rays, including edge detection of the outline of the proximal femur that involved breaking edges detected into segments and characterizing the orientation of each segment.
  • Each edge segment was then referenced to a map of expected proximal femur edge orientation and to a map of the probability of edge location. Edge segments that did not conform to the expected orientation or which were in low probability regions were removed. Morphology operations were applied to the edge image(s) to connect any discontinuities.
  • the edge image formed an enclosed boundary of the proximal femur. The region within the boundary was then combined with the binary image from global thresholding to form the final mask of the proximal femur.
  • edge detection was applied. Morphology operations were applied to connect edge discontinuities. Segments were formed within enclosed edges. The area and the major axis length of each segment were then measured. The regions were also superimposed on the original gray level image and average gray level within each region was measured.
  • the cortex was identified as those segments connected to the boundary of the proximal femur mask with the greatest area, longest major axis length and a mean gray level about the average gray level of all enclosed segments within the proximal femur mask.
  • the segment identified as cortex was then skeletonized.
  • the orientation of the cortex skeleton was verified to conform to the orientation map of the proximal femur edge.
  • Euclidean distance transform was applied to the binary image of the segment.
  • the values of distance transform value along the skeleton were sampled and their average, standard deviation, minimum, maximum and mod determined.
  • Marrow spacing was characterized by determining watershed segmentation of gray level trabecular structures on the hip images; essentially as described in Russ “The Image Processing Handbook,” 3 rd . ed. pp. 494-501. This analysis take the gray level contrast between the marrow spacing and adjacent trabecular structures into account.
  • the segments of marrow spacing generated using watershed segmentation were measured for the area, eccentricity, orientation, and the average gray level on the x-ray image within the segment. Mean, standard deviation, minimum, maximum and mod. were determined for each segment.
  • various structural and/or macro-anatomical parameters were assessed for several ROIs ( FIG. 10 ).
  • FIG. 12 Fracture load and resultant equilibrium forces and moments at the distal end of the femur were measured continuously.
  • FIG. 11 shows various results of biomechanical testing.
  • a hip x-ray of cadaver pelvis was exposed using standard clinical procedure and equipment.
  • the radiograph film was developed and digitized.
  • the image was then analyzed to obtain micro-structure, and macro-anatomical parameters.
  • the local maximum spacing, standard deviation of cortical thickness of RO13, maximum cortical thickness of RO15, and mean node-free end length for RO13 were used to predict load required to fracture the cadaver hip using the coefficients of multivariate linear regression stored in the fracture load reference database.

Abstract

Methods of predicting bone or joint disease in a subject are disclosed. Methods of determining the effect of a candidate agent on any subject's risk of developing bone or joint disease are also disclosed. A method for generating a parameter map from a bone image of a subject includes obtaining the bone image of the subject, defining two or more regions of interest (ROIs) in the image, analyzing a plurality of positions in the ROIs to obtain measurements for one or more bone microarchitecture parameters and one or more bone macro-anatomy parameters, and generating the parameter map from the measurements.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. Ser. No. 12/948,276, filed Nov. 17, 2010, now U.S. Pat. No. 8,818,484, which in turn is a continuation of U.S. Ser. No. 10/753,976, filed Jan. 7, 2004, now U.S. Pat. No. 7,840,247, which in turn is a continuation-in-part of U.S. Ser. No. 10/665,725, filed Sep. 16, 2003, which in turn claims the benefit of U.S. Provisional Patent Application Ser. No. 60/411,413, filed on Sep. 16, 2002 and also claims the benefit of U.S. Provisional Patent Application Ser. No. 60/438,641, filed on Jan. 7, 2003, from which applications priority is hereby claimed under 35 USC §§119/120, the disclosures of which are incorporated by reference herein in their entirety.
  • TECHNICAL FIELD
  • This invention relates to using imaging methods for diagnosis, prognostication, monitoring and management of disease, particularly where that disease affects the musculoskeletal system. This invention identifies novel imaging markers for use in diagnosis, prognostication, monitoring and management of disease, including musculoskeletal disease.
  • BACKGROUND
  • Osteoporosis and osteoarthritis are among the most common conditions to affect the musculoskeletal system, as well as frequent causes of locomotor pain and disability. Osteoporosis can occur in both human and animal subjects (e.g. horses). Osteoporosis (OP) and osteoarthritis (OA) occur in a substantial portion of the human population over the age of fifty. The National Osteoporosis Foundation estimates that as many as 44 million Americans are affected by osteoporosis and low bone mass. In 1997 the estimated cost for osteoporosis related fractures was $13 billion. That figure increased to $17 billion in 2002 and is projected to increase to $210-240 billion by 2040. Currently it is expected that one in two women over the age of 50 will suffer an osteoporosis-related fracture.
  • Imaging techniques are important diagnostic tools, particularly for bone related conditions such as OP and OA. Currently available techniques for the noninvasive assessment of the skeleton for the diagnosis of osteoporosis or the evaluation of an increased risk of fracture include dual x-ray absorptiometry (DXA) (Eastell et al. (1998) New Engl J. Med 338:736-746); quantitative computed tomography (QCT) (Cann (1988) Radiology 166:509-522); peripheral DXA (PDXA) (Patel et al. (1999) J Clin Densitom 2:397-401); peripheral QCT (PQCT) (Gluer et. al. (1997) Semin Nucl Med 27:229-247); x-ray image absorptiometry (RA) (Gluer et. al. (1997) Semin Nucl Med 27:229-247); and quantitative ultrasound (QUS) (Njeh et al. “Quantitative Ultrasound: Assessment of Osteoporosis and Bone Status” 1999, Martin-Dunitz, London England; U.S. Pat. No. 6,077, 224, incorporated herein by reference in its entirety). (See, also, WO 9945845; WO 99/08597; and U.S. Pat. No. 6,246,745).
  • DXA of the spine and hip has established itself as the most widely used method of measuring BMD. Tothill, P. and D. W. Pye, (1992) Br J Radiol 65:807-813. The fundamental principle behind DXA is the measurement of the transmission through the body of x-rays of 2 different photon energy levels. Because of the dependence of the attenuation coefficient on the atomic number and photon energy, measurement of the transmission factors at 2 energy levels enables the area densities (i.e., the mass per unit projected area) of 2 different types of tissue to be inferred. In DXA scans, these are taken to be bone mineral (hydroxyapatite) and soft tissue, respectively. However, it is widely recognized that the accuracy of DXA scans is limited by the variable composition of soft tissue. Because of its higher hydrogen content, the attenuation coefficient of fat is different from that of lean tissue. Differences in the soft tissue composition in the path of the x-ray beam through bone compared with the adjacent soft tissue reference area cause errors in the BMD measurements, according to the results of several studies. Tothill, P. and D. W. Pye, (1992) Br J Radiol, 65:807-813; Svendsen, O. L., et al., (1995) J Bone Min Res 10:868-873. Moreover, DXA systems are large and expensive, ranging in price between $75,000 and $150,000.
  • Quantitative computed tomography (QCT) is usually applied to measure the trabecular bone in the vertebral bodies. Cann (1988) Radiology 166:509-522. QCT studies are generally performed using a single kV setting (single-energy QCT), when the principal source of error is the variable composition of the bone marrow. However, a dual-kV scan (dual-energy QCT) is also possible. This reduces the accuracy errors but at the price of poorer precision and higher radiation dose. Like DXA, however, QCT are very expensive and the use of such equipment is currently limited to few research centers.
  • Quantitative ultrasound (QUS) is a technique for measuring the peripheral skeleton. Njeh et al. (1997) Osteoporosis Int 7:7-22; Njeh et al. Quantitative Ultrasound: Assessment of Osteoporosis and Bone Status. 1999, London, England: Martin Dunitz. There is a wide variety of equipment available, with most devices using the heel as the measurement site. A sonographic pulse passing through bone is strongly attenuated as the signal is scattered and absorbed by trabeculae. Attenuation increases linearly with frequency, and the slope of the relationship is referred to as broadband ultrasonic attenuation (BUA; units: dB/MHz). BUA is reduced in patients with osteoporosis because there are fewer trabeculae in the calcaneus to attenuate the signal. In addition to BUA, most QUS systems also measure the speed of sound (SOS) in the heel by dividing the distance between the sonographic transducers by the propagation time (units: m/s). SOS values are reduced in patients with osteoporosis because with the loss of mineralized bone, the elastic modulus of the bone is decreased. There remain, however, several limitations to QUS measurements. The success of QUS in predicting fracture risk in younger patients remains uncertain. Another difficulty with QUS measurements is that they are not readily encompassed within the WHO definitions of osteoporosis and osteopenia. Moreover, no intervention thresholds have been developed. Thus, measurements cannot be used for therapeutic decision-making.
  • There are also several technical limitations to QUS. Many devices use a foot support that positions the patient's heel between fixed transducers. Thus, the measurement site is not readily adapted to different sizes and shapes of the calcaneus, and the exact anatomic site of the measurement varies from patient to patient. It is generally agreed that the relatively poor precision of QUS measurements makes most devices unsuitable for monitoring patients' response to treatment. Gluer (1997) J Bone Min Res 12:1280-1288.
  • Radiographic absorptiometry (RA) is a technique that was developed many years ago for assessing bone density in the hand, but the technique has recently attracted renewed interest. Gluer et al. (1997) Semin Nucl Med 27:229-247. With this technique, BMD is measured in the phalanges. The principal disadvantage of RA of the hand is the relative lack of high turnover trabecular bone. For this reason, RA of the hand has limited sensitivity in detecting osteoporosis and is not very useful for monitoring therapy-induced changes.
  • Peripheral x-ray absorptiometry methods such as those described above are substantially cheaper than DXA and QCT with system prices ranging between $15,000 and $35,000. However, epidemiologic studies have shown that the discriminatory ability of peripheral BMD measurements to predict spine and hip fractures is lower than when spine and hip BMD measurements are used. Cummings et al. (1993) Lancet 341:72-75; Marshall et al. (1996) Br Med J 312:1254-1259. The main reason for this is the lack of trabecular bone at the measurement sites used with these techniques. In addition, changes in forearm or hand BMD in response to hormone replacement therapy, bisphosphonates, and selective estrogen receptor modulators are relatively small, making such measurements less suitable than measurements of principally trabecular bone for monitoring response to treatment. Faulkner (1998) J Clin Densitom 1:279-285; Hoskings et al. (1998) N Engl J Med 338:485-492. Although attempts to obtain information on bone mineral density from dental x-rays have been attempted (See, e.g., Shrout et al. (2000) J. Periodonol. 71:335-340; Verhoeven et al. (1998) Clin Oral Implants Res 9(5):333-342), these have not provided accurate and reliable results.
  • Furthermore, current methods and devices do not generally take into account bone structure analyses. See, e.g., Ruttimann et al. (1992) Oral Surg Oral Med Oral Pathol 74:98-110; Southard & Southard (1992) Oral Surg Oral Med Oral Pathol 73:751-9; White & Rudolph, (1999) Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88:628-35.
  • The present invention discloses novel methods and techniques for predicting musculoskeletal disease, particularly methods and compositions that result in the ability to obtain accurate predictions about disease based on bone mineral density and/or bone structure information obtained from images (e.g., radiographic images) and data.
  • SUMMARY OF THE EMBODIMENTS
  • The invention discloses a method for analyzing at least one of bone mineral density, bone structure and surrounding tissue. The method typically comprises: (a) obtaining an image of a subject; (b) locating a region of interest on the image; (c) obtaining data from the region of interest; and (d) deriving data selected from the group of qualitative and quantitative from the image data obtained at step c.
  • A system is also provided for predicting a disease. Any of these systems can include the steps of: (a) obtaining image data of a subject; (b) obtaining data from the image data wherein the data obtained is at least one of quantitative and qualitative data; and (c) comparing the at least one of quantitative and qualitative data in step b to at least one of: a database of at least one of quantitative and qualitative data obtained from a group of subjects; at least one of quantitative and qualitative data obtained from the subject; and at least one of a quantitative and qualitative data obtained from the subject at time Tn.
  • In certain aspects, described herein are methods of diagnosing, monitoring and/or predicting bone or articular disease (e.g., the risk of fracture) in a subject, the method comprising the steps of: determining one or more micro-structural parameters, one or more macroanatomical parameters or biomechanical parameters of a joint in said subject; and combining at least two of said parameters to predict the risk of bone or articular disease. The micro-structural, macroanatomical and/or biomechanical parameters may be, for example, one or more of the measurements/parameters shown in Tables 1, 2 and/or 3. In certain embodiments, one or more micro-structural parameters and one or more macro-anatomical parameters are combined. In other embodiments, one or more micro-structural parameters and one or more biomechanical parameters are combined. In further embodiments, one or more macroanatomical parameters and one or more biomechanical parameters are combined. In still further embodiments, one or more macroanatomical parameters, one or more micro-structural parameters and one or more biomechanical parameters are combined.
  • In any of the methods described herein, the comparing may be comprise univariate, bivariate and/or multivariate statistical analysis of one or more of the parameters. In certain embodiments, the methods may further comprise comparing said parameters to data derived from a reference database of known disease parameters.
  • In any of the methods described herein, the parameters are determined from an image obtained from the subject. In certain embodiments, the image comprises one or more regions of bone (e.g., patella, femur, tibia, fibula, pelvis, spine, etc). The image may be automatically or manually divided into two or more regions of interest. Furthermore, in any of the methods described herein, the image may be, for example, an x-ray image, a CT scan, an MRI or the like and optionally includes one or more calibration phantoms.
  • In any of the methods described herein, the predicting includes performing univariate, bivariate or multivariate statistical analysis of the analyzed data and referencing the statistical analysis values to a fracture risk model. Fracture risk models can comprise, for example, data derived from a reference database of known fracture loads with their corresponding values of macro-anatomical, micro-anatomical parameters, and/or clinical risk factors.
  • In another aspect, the invention includes a method of determining the effect of a candidate agent on a subject's prognosis for musculoskeletal disease comprising: predicting a first risk of musculoskeletal disease in subject according to any of the predictive methods described herein; administering a candidate agent to the subject; predicting a second risk of the musculoskeletal disease in the subject according to any of the predictive methods described herein; and comparing the first and second risks, thereby determining the effect of the candidate on the subject's prognosis for the disease. In any of these methods, the candidate agent can be administered to the subject in any modality, for example, by injection (intramuscular, subcutaneous, intravenous), by oral administration (e.g., ingestion), topical administration, mucosal administration or the like. Furthermore, the candidate agent may be a small molecule, a pharmaceutical, a biopharmaceutical, an agropharmaceuticals and/or combinations thereof.
  • In other aspects, the invention includes a kit that is provided for aiding in the prediction of musculoskeletal disease (e.g., fracture risk). The kit typically comprises a software program that uses information obtained from an image to predict the risk or disease (e.g., fracture). The kit can also include a database of measurements for comparison purposes. Additionally, the kit can include a subset of a database of measurements for comparisons.
  • In any of these methods, systems or kits, additional steps can be provided. Such additional steps include, for example, enhancing image data.
  • Suitable subjects for these steps include for example mammals, humans and horses. Suitable anatomical regions of subjects include, for example, dental, spine, hip, knee and bone core x-rays.
  • A variety of systems can be employed to practice the inventions. Typically at least one of the steps of any of the methods is performed on a first computer. Although, it is possible to have an arrangement where at least one of the steps of the method is performed on a first computer and at least one of the steps of the method is performed on a second computer. In this scenario the first computer and the second computer are typically connected. Suitable connections include, for example, a peer to peer network, direct link, intranet, and internet.
  • It is important to note that any or all of the steps of the inventions disclosed can be repeated one or more times in series or in parallel with or without the repetition of other steps in the various methods. This includes, for example repeating the step of locating a region of interest, or obtaining image data.
  • Data can also be converted from 2D to 3D to 4D and back; or from 2D to 4D. Data conversion can occur at multiple points of processing the information. For example, data conversion can occur before or after pattern evaluation and/or analysis.
  • Any data obtained, extracted or generated under any of the methods can be compared to a database, a subset of a database, or data previously obtained, extracted or generated from the subject. For example, known fracture load can be determined for a variety of subjects and some or all of this database can be used to predict fracture risk by correlating one or more macro-anatomical or structural parameters (Tables 1, 2 and/or 3) with data from a reference database of fracture load for age, sex, race, height and weight matched individuals.
  • The present invention provides methods that allow for the analysis of bone mineral density, bone and/or cartilage structure and morphology and/or surrounding tissue from images including electronic images and, accordingly, allows for the evaluation of the effect(s) of an agent (or agents) on bone and/or cartilage. It is important to note that an effect on bone and/or cartilage can occur in agents intended to have an effect, such as a therapeutic effect, on bone and/or cartilage as well as agents intended to primarily effect other tissues in the body but which have a secondary, or tangential, effect on bone and/or cartilage. The images (e. g., x-ray images) can be, for example, dental, hip, spine or other radiographs and can be taken from any mammal. The images can be in electronic format.
  • The invention includes a method to derive quantitative information on bone structure and/or bone mineral density from an image comprising (a) obtaining an image, wherein the image optionally includes an external standard for determining bone density and/or structure; and (b) analyzing the image obtained in step (a) to derive quantitative information on bone structure. The image is taken of a region of interest (ROI). Suitable ROI include, for example, a hip radiograph or a dental x-ray obtained on dental x-ray film, including the mandible, maxilla or one or more teeth. In certain embodiments, the image is obtained digitally, for example using a selenium detector system, a silicon detector system or a computed radiography system. In other embodiments, the image can be digitized from film, or another suitable source, for analysis.
  • A method is included where one or more candidate agents can be tested for its effects on bone. Again, the effect can be a primary effect or a secondary effect. For example, images obtained from the subject can be evaluated prior to administration of a candidate agent to predict the risk of disease in the absence of the agent. After administration of the candidate agent(s), an electronic image of the same portion of a bone of the subject can be obtained and analyzed as described herein to predict the risk of musculoskeletal disease. The risk of disease prior to administration of the candidate agent and after administration can then be compared to determine if the agent had any effect on disease prognosis. Information on bone structure can relate to a variety of parameters, including the parameters shown in Table 1, Table 2 and Table 3, infra. The images or data may also be compared to a database of images or data (e.g., “known” images or data). The candidate agent can, for example, be molecules, proteins, peptides, naturally occurring substances, chemically synthesized substances, or combinations and cocktails thereof. Typically, an agent includes one or more drugs. Further, the agent can be evaluated for the ability to effect bone diseases such as the risk of bone fracture (e.g., osteoporotic fracture).
  • In any of the methods described herein, the analysis can comprise using one or more computer programs (or units). Additionally, the analysis can comprise identifying one or more regions of interest (ROI) in the image, either prior to, concurrently or after analyzing the image, e.g. for information on bone mineral density and/or bone structure. The bone density information can be, for example, areas of highest, lowest or median density. Bone structural information can be, for example, one or more of the parameters shown in Table 1, Table 2 and Table 3. The various analyses can be performed concurrently or in series. Further, when using two or more indices each of the indices can be weighted equally or differently, or combinations thereof where more than two indices are employed. Additionally, any of these methods can also include analyzing the image for bone mineral density information using any of the methods described herein.
  • Any of the methods described herein can further comprise applying one or more correction factors to the data obtained from the image. For example, correction factors can be programmed into a computer unit. The computer unit can be the same one that performs the analysis of the image or can be a different unit. In certain embodiments, the correction factors account for the variation in soft-tissue thickness in individual subjects.
  • These and other embodiments of the subject invention will readily occur to those of skill in the art in light of the disclosure herein.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIGS. 1A AND B are block diagrams showing the steps for extracting data from an image and then deriving quantitative and/or qualitative data from the image.
  • FIGS. 2A-C are diagrams showing an image taken of a region of anatomical interest further illustrating possible locations of regions of interest for analysis.
  • FIGS. 3A-J illustrate various abnormalities that might occur including, for example, cartilage defects, bone marrow edema, subchondral sclerosis, osteophytes and cysts.
  • FIGS. 4A AND B are block diagrams of the method of FIG. 1A showing that the steps can be repeated.
  • FIGS. 5A-E are block diagrams illustrating steps involved in evaluating patterns in an image of a region of interest.
  • FIG. 6A-E are block diagrams illustrating steps involved in deriving quantitative and qualitative data from an image in conjunction with administering candidate molecules or drugs for evaluation.
  • FIGS. 7A-D are block diagrams illustrating steps involved in comparing derived quantitative and qualitative information to a database or to information obtained at a previous time.
  • FIGS. 8A-D are block diagrams illustrating steps involved in comparing converting an image to a pattern of normal and diseased tissue
  • FIG. 9 is a diagram showing the use one or more devices in the process of developing a degeneration pattern and using a database for degeneration patterns.
  • FIG. 10 depicts regions of interest (ROIs) analyzed in Example 1.
  • FIG. 11 depicts results of biomechanical testing of 15 cadaveric hips and femurs.
  • FIG. 12A-B, are reproductions of x-ray images depicting an exemplary induced fracture in cadaveric femur resulting from biomechanical testing and load.
  • FIG. 13 is a graph depicting correlation of DXA femoral neck bone mineral density (BMD) versus biochemical fracture load as evaluated in 15 fresh cadaveric hip samples.
  • FIG. 14A-C are graphs depicting correlation of bone structure versus mechanical fracture load. FIG. 14A depicts correlation of maximum marrow spacing v. fracture load. FIG. 14B depicts correlation of maximum marrow spacing (log) v. fracture load. FIG. 14C depicts correlation of percentage of trabecular area v. fracture load.
  • FIG. 15A-C are graphs depicting correlation of macro-anatomical features versus biomechanical fracture load. FIG. 15A depicts correlation of cortical thickness v. fracture load. FIG. 15B depicts correlation of hip axis length (HAL) V. fracture load. FIG. 15C depicts correlation of cortical thickness (standard deviation) versus fracture load.
  • FIG. 16 is a graph depicting multivariate analysis using a combination of bone structural and macro-anatomical parameters and shows the correlation of predicted fracture load to actual fracture load.
  • DETAILED DESCRIPTION OF SPECIFIC EMBODIMENTS
  • The following description is presented to enable any person skilled in the art to make and use the invention. Various modifications to the embodiments described will be readily apparent to those skilled in the art, and the generic principles defined herein can be applied to other embodiments and applications without departing from the spirit and scope of the present invention as defined by the appended claims. Thus, the present invention is not intended to be limited to the embodiments shown, but is to be accorded the widest scope consistent with the principles and features disclosed herein. To the extent necessary to achieve a complete understanding of the invention disclosed, the specification and drawings of all issued patents, patent publications, and patent applications cited in this application are incorporated herein by reference.
  • The practice of the present invention employs, unless otherwise indicated, currently conventional methods of imaging and image processing within the skill of the art. Such techniques are explained fully in the literature. See, e.g., WO 02/22014, X-Ray Structure Determination: A Practical Guide, 2nd Edition, editors Stout and Jensen, 1989, John Wiley & Sons, publisher; Body CT: A Practical Approach, editor Slone, 1999, McGraw-Hill publisher; The Essential Physics of Medical Imaging, editors Bushberg, Seibert, Leidholdt Jr & Boone, 2002, Lippincott, Williams & Wilkins; X-ray Diagnosis: A Physician's Approach, editor Lam, 1998 Springer-Verlag, publisher; Dental Radiology: Understanding the X-Ray Image, editor Laetitia Brocklebank 1997, Oxford University Press publisher; and Digital Image Processing, editor Kenneth R. Castleman, 1996 Prentice Hall, publisher; The Image Processing Handbook, editor John C. Russ, 3rd Edition, 1998, CRC Press; Active Contours: The Application of Techniques from Graphics, Vision, Control Theory and Statistics to Visual Tracking of Shapes in Motion, Editors Andrew Blake, Michael Isard, 1999 Springer Verlag. As will be appreciated by those of skill in the art, as the field of imaging continues to advance methods of imaging currently employed can evolve over time. Thus, any imaging method or technique that is currently employed is appropriate for application of the teachings of this invention as well as techniques that can be developed in the future. A further detailed description of imaging methods is not provided in order to avoid obscuring the invention.
  • As shown in FIG. 1A, the first step is to locate a part of the body of a subject, for example in a human body, for study 98. The part of the body located for study is the region of anatomical interest (RAI). In locating a part of the body for study, a determination is made to, for example, take an image or a series of images of the body at a particular location, e.g. hip, dental, spine, etc. Images include, for example, conventional x-ray images, x-ray tomosynthesis, ultrasound (including A-scan, B-scan and C-scan) computed tomography (CT scan), magnetic resonance imaging (MRI), optical coherence tomography, single photon emission tomography (SPECT), and positron emission tomography, or such other imaging tools that a person of skill in the art would find useful in practicing the invention. Once the image is taken, a region of interest (ROI) can be located within the image 100. Algorithms can be used to automatically place regions of interest in a particular image. See, e.g., Example 1 describing automatic placement of ROIs in femurs. Image data is extracted from the image 102. Finally, quantitative and/or qualitative data is extracted from the image data 120. The quantitative and/or qualitative data extracted from the image includes, for example, the parameters and measurements shown in Table 1, Table 2 or 5 Table 3.
  • Each step of locating a part of the body for study 98, optionally locating a region of interest 100, obtaining image data 102, and deriving data 120, can be repeated one or more times 99,101, 103, 121, respectively, as desired.
  • As shown in FIG. 1B image data can be optionally enhanced 104 by applying image processing techniques, such as noise filtering or diffusion filtering, to facilitate further analysis. Similar to the process shown in FIG. 1A, locating a part of the body for study 98, optionally locating a region of interest 100, obtaining image data 102, enhancing image data 104, and deriving data 120, can be repeated one or more times 99,101, 103, 105, 121, respectively, as desired.
  • As will be appreciated by those of skill in the art, the parameters and measurements shown in Table 1 are provided for illustration purposes. It will be apparent that the terms micro-structural parameters, micro-architecture, micro-anatomic structure, micro-structural and trabecular architecture may be used interchangably. In addition, other parameters and measurements, ratios, derived values or indices can be used to extract quantitative and/or qualitative information about the ROI without departing from the scope of the invention. Additionally, where multiple ROI or multiple derivatives of data are used, the parameter measured can be the same parameter or a different parameter without departing from the scope of the invention. Additionally, data from different ROIs can be combined or compared as desired.
  • Additional measurements can be performed that are selected based on the anatomical structure to be studied as described below.
  • TABLE 1
    Representative Parameters Measured with Quantitative
    and Qualitative Image Analysis Methods
    PARAMETER MEASUREMENTS
    Bone density and Calibration phantom equivalent thickness
    microstructural (Average intensity value of the region of interest expressed as
    parameters thickness of calibration phantom that would produce the equivalent
    intensity)
    Trabecular contrast
    Standard deviation of background subtracted ROI
    Coefficient of Variation of ROI (Standard deviation/mean)
    (Trabecular equivalent thickness/Marrow equivalent thickness)
    Fractal dimension
    Hough transform
    Fourier spectral analysis
    (Mean transform coefficient absolute value and mean spatial first
    moment)
    Predominant orientation of spatial energy spectrum
    Trabecular area
    (Pixel count of extracted trabeculae)
    Trabecular area/Total area
    Trabecular perimeter
    (Count of trabecular pixels with marrow pixels in their neighborhood,
    proximity or vicinity)
    Trabecular distance transform
    (For each trabecular pixel, calculation of distance to closest marrow
    pixel)
    Marrow distance transform
    (For each marrow pixel, calculation of distance to closest trabecular
    pixel)
    Trabecular distance transform regional maximal values (mean, min.,
    max, std. Dev).
    (Describes thickness and thickness variation of trabeculae)
    Marrow distance transform regional maximal values (mean, min., max,
    std. Dev)
    Star volume
    (Mean volume of all the parts of an object which can be seen
    unobscured from a random point inside the object in all possible
    directions)
    Trabecular Bone Pattern Factor
    (TBPf = (P1 − P2)/(A1 − A2) where P1 and A1 are the perimeter
    length and trabecular bone area before dilation and P2 and A2
    corresponding values after a single pixel dilation, measure of
    connectivity)
    Connected skeleton count or Trees (T)
    Node count (N)
    Segment count (S)
    Node-to-node segment count (NN)
    Node-to-free-end segment count (NF)
    Node-to-node segment length (NNL)
    Node-to-free-end segment length (NFL)
    Free-end-to-free-end segment length (FFL)
    Node-to-node total struts length (NN.TSL)
    Free-end-to-free-ends total struts length(FF.TSL)
    Total struts length (TSL)
    FF.TSL/TSL
    NN.TSL/TSL
    Loop count (Lo)
    Loop area
    Mean distance transform values for each connected skeleton
    Mean distance transform values for each segment (Tb.Th)
    Mean distance transform values for each node-to-node segment
    (Tb.Th.NN)
    Mean distance transform values for each node-to-free-end segment
    (Tb.Th.NF)
    Orientation (angle) of each segment
    Angle between segments
    Length-thickness ratios (NNL/Tb.Th.NN) and (NFL/Tb.Th.NF)
    Interconnectivity index (ICI) ICI = (N * NN)/(T * (NF + 1))
    Cartilage and Total cartilage volume
    cartilage Partial/Focal cartilage volume
    defect/diseased Cartilage thickness distribution (thickness map)
    cartilage parameters Mean cartilage thickness for total region or focal region
    Median cartilage thickness for total region or focal region
    Maximum cartilage thickness for total region or focal region
    Minimum cartilage thickness for total region or focal region
    3D cartilage surface information for total region or focal region
    Cartilage curvature analysis for total region or focal region
    Volume of cartilage defect/diseased cartilage
    Depth of cartilage defect/diseased cartilage
    Area of cartilage defect/diseased cartilage
    2D or 3D location of cartilage defect/diseased cartilage in articular
    surface
    2D or 3D location of cartilage defect/diseased cartilage in
    relationship to weight-bearing area
    Ratio: diameter of cartilage defect or diseased cartilage/thickness of
    surrounding normal cartilage
    Ratio: depth of cartilage defect or diseased cartilage/thickness of
    surrounding normal cartilage
    Ratio: volume of cartilage defect or diseased cartilage/thickness of
    surrounding normal cartilage
    Ratio: surface area of cartilage defect or diseased cartilage/total
    joint or articular surface area
    Ratio: volume of cartilage defect or diseased cartilage/total cartilage
    volume
    Other articular Presence or absence of bone marrow edema
    parameters Volume of bone marrow edema
    Volume of bone marrow edema normalized by width, area, size,
    volume of femoral condyle(s)/tibial plateau/patella - other bones
    in other joints
    Presence or absence of osteophytes
    Presence or absence of subchondral cysts
    Presence or absence of subchondral sclerosis
    Volume of osteophytes
    Volume of subchondral cysts
    Volume of subchondral sclerosis
    Area of bone marrow edema
    Area of osteophytes
    Area of subchondral cysts
    Area of subchondral sclerosis
    Depth of bone marrow edema
    Depth of osteophytes
    Depth of subchondral cysts
    Depth of subchondral sclerosis
    Volume, area, depth of osteophytes, subchondral cysts, subchondral
    sclerosis normalized by width, area, size, volume of femoral
    condyle(s)/tibial plateau/patella - other bones in other joints
    Presence or absence of meniscal tear
    Presence or absence of cruciate ligament tear
    Presence or absence of collateral ligament tear
    Volume of menisci
    Ratio of volume of normal to torn/damaged or degenerated meniscal
    tissue
    Ratio of surface area of normal to torn/damaged or degenerated
    meniscal tissue
    Ratio of surface area of normal to torn/damaged or degenerated
    meniscal tissue to total joint or cartilage surface area
    Ratio of surface area of torn/damaged or degenerated meniscal
    tissue to total joint or cartilage surface area
    Size ratio of opposing articular surfaces
    Meniscal subluxation/dislocation in mm
    Index combining different articular parameters which can also
    include
    Presence or absence of cruciate or collateral ligament tear
    Body mass index, weight, height
    3D surface contour information of subchondral bone
    Actual or predicted knee flexion angle during gait cycle
    (latter based on gait patterns from subjects with matching
    demographic data retrieved from motion profile database)
    Predicted knee rotation during gait cycle
    Predicted knee displacement during gait cycle
    Predicted load bearing line on cartilage surface during gait cycle and
    measurement of distance between load bearing line and cartilage
    defect/diseased cartilage
    Predicted load bearing area on cartilage surface during gait cycle
    and measurement of distance between load bearing area and
    cartilage defect/diseased cartilage
    Predicted load bearing line on cartilage surface during standing or
    different degrees of knee flexion and extension and measurement
    of distance between load bearing line and cartilage
    defect/diseased cartilage
    Predicted load bearing area on cartilage surface during standing or
    different degrees of knee flexion and extension and measurement
    of distance between load bearing area and cartilage
    defect/diseased cartilage
    Ratio of load bearing area to area of cartilage defect/diseased
    cartilage
    Percentage of load bearing area affected by cartilage disease
    Location of cartilage defect within load bearing area
    Load applied to cartilage defect, area of diseased cartilage
    Load applied to cartilage adjacent to cartilage defect, area of
    diseased cartilage
  • Once the data is extracted from the image it can be manipulated to assess the severity of the disease and to determine disease staging (e.g., mild, moderate, severe or a numerical value or index). The information can also be used to monitor progression of the disease and/or the efficacy of any interventional steps that have been taken. Finally, the information can be used to predict the progression of the disease or to randomize patient groups in clinical trials.
  • FIG. 2A illustrates an image 200 taken of an RAI, shown as 202. As shown in FIG. 2A, a single region of interest (ROI) 210 has been identified within the image. The ROI 210 can take up the entire image 200, or nearly the entire image. As shown in FIG. 2B more than one ROI can be identified in an image. In this example, a first ROI 220 is depicted in one region of the image 200, and a second ROI 222 is depicted within the image. In this instance, neither of these ROI overlap or abut. As will be appreciated by a person of skill in the art, the number of ROI identified in an image 200 is not limited to the two depicted. Turning now to FIG. 2C another embodiment showing two ROI for illustration purposes is shown. In this instance, the first ROI 230 and the second ROI 232, are partially overlapping. As will be appreciated by those of skill in the art, where multiple ROI are used any or all of the ROI can be organized such that it does not overlap, it abuts without overlapping, it overlaps partially, it overlaps completely (for example where a first ROI is located completely within a second identified ROI), and combinations thereof. Further the number of ROI per image 200 can range from one (ROI1) to n (ROIn) where n is the number of ROI to be analyzed.
  • Bone density, microarchitecture, macro-anatomic and/or biomechanical (e.g. derived using finite element modeling) analyses can be applied within a region of predefined size and shape and position. This region of interest can also be referred to as a “window.” Processing can be applied repeatedly within the window at different positions of the image. For example, a field of sampling points can be generated and the analysis performed at these points. The results of the analyses for each parameter can be stored in a matrix space, e.g., where its position corresponds to the position of the sampling point where the analysis occurred, thereby forming a map of the spatial distribution of the parameter (a parameter map). The sampling field can have regular intervals or irregular intervals with varying density across the image. The window can have variable size and shape, for example to account for different patient size or anatomy.
  • The amount of overlap between the windows can be determined, for example, using the interval or density of the sampling points (and resolution of the parameter maps). Thus, the density of sampling points is set higher in regions where higher resolution is desired and set lower where moderate resolution is sufficient, in order to improve processing efficiency. The size and shape of the window would determine the local specificity of the parameter. Window size is preferably set such that it encloses most of the structure being measured. Oversized windows are generally avoided to help ensure that local specificity is not lost.
  • The shape of the window can be varied to have the same orientation and/or geometry of the local structure being measured to minimize the amount of structure clipping and to maximize local specificity. Thus, both 2D and/or 3D windows can be used, as well as combinations thereof, depending on the nature of the image and data to be acquired.
  • In another embodiment, bone density, microarchitecture, macro-anatomic and/or biomechanical (e.g. derived using finite element modeling) analyses can be applied within a region of predefined size and shape and position. The region is generally selected to include most, or all, of the anatomic region under investigation and, preferably, the parameters can be assessed on a pixel-by-pixel basis (e.g., in the case of 2D or 3D images) or a voxel-by-voxel basis in the case of cross-sectional or volumetric images (e.g., 3D images obtained using MR and/or CT). Alternatively, the analysis can be applied to clusters of pixels or voxels wherein the size of the clusters is typically selected to represent a compromise between spatial resolution and processing speed. Each type of analysis can yield a parameter map.
  • Parameter maps can be based on measurement of one or more parameters in the image or window; however, parameter maps can also be derived using statistical methods. In one embodiment, such statistical comparisons can include comparison of data to a reference population, e.g. using a z-score or a T-score. Thus, parameter maps can include a display of z-scores or T-scores.
  • Additional measurements relating to the site to be measured can also be taken. For example, measurements can be directed to dental, spine, hip, knee or bone cores. Examples of suitable site specific measurements are shown in Table 2.
  • TABLE 2
    Site specific measurement of b ne parameters
    Parameters specific to All microarchitecture parameters on structures parallel to stress
    hip images lines
    All microarchitecture parameters on structures perpendicular to
    stress lines
    Geometry
    Shaft angle
    Neck angle
    Average and minimum diameter of femur neck
    Hip axis length
    CCD (caput-collum-diaphysis) angle
    Width of trochanteric region
    Largest cross-section of femur head
    Standard deviation of cortical bone thickness within ROI
    Minimum, maximum, mean and median thickness of cortical
    bone within ROI
    Hip joint space width
    Parameters specific to All microarchitecture parameters on vertical structures
    spine images All microarchitecture parameters on horizontal structures
    Geometry
    Superior endplate cortical thickness (anterior, center, posterior)
    Inferior endplate cortical thickness (anterior, center, posterior)
    Anterior vertebral wall cortical thickness (superior, center,
    inferior)
    Posterior vertebral wall cortical thickness (superior, center,
    inferior)
    Superior aspect of pedicle cortical thickness
    inferior aspect of pedicle cortical thickness
    Vertebral height (anterior, center, posterior)
    Vertebral diameter (superior, center, inferior),
    Pedicle thickness (supero-inferior direction).
    Maximum vertebral height
    Minimum vertebral height
    Average vertebral height
    Anterior vertebral height
    Medial vertebral height
    Posterior vertebral height
    Maximum inter-vertebral height
    Minimum inter-vertebral height
    Average inter-vertebral height
    Parameters specific to Average medial joint space width
    knee images Minimum medial joint space width
    Maximum medial joint space width
    Average lateral joint space width
    Minimum lateral joint space width
    Maximum lateral joint space width
  • As will be appreciated by those of skill in the art, measurement and image processing techniques are adaptable to be applicable to both microarchitecture and macro-anatomical structures. Examples of these measurements are shown in Table 3.
  • TABLE 3
    Measurements applicable on Microarchitecture and Macro-anatomical Structures
    Average density Calibrated density of ROI
    measurement
    Measurements on micro- The following parameters are derived from the extracted structures:
    anatomical structures of Calibrated density of extracted structures
    dental, spine, hip, knee or Calibrated density of background
    bone cores images Average intensity of extracted structures
    Average intensity of background (area other than extracted
    structures)
    Structural contrast (average intensity of extracted structures/
    average intensity of background)
    Calibrated structural contrast (calibrated density extracted
    structures/calibrated density of background)
    Total area of extracted structures
    Total area of ROI
    Area of extracted structures normalized by total area of ROI
    Boundary lengths (perimeter) of extracted normalized by total
    area of ROI
    Number of structures normalized by area of ROI
    Trabecular bone pattern factor; measures concavity and
    convexity of structures
    Star volume of extracted structures
    Star volume of background
    Number of loops normalized by area of ROI
    Measurements on The following statistics are measured from the distance transform
    Distance transform of regional maximum values:
    extracted structures Average regional maximum thickness
    Standard deviation of regional maximum thickness
    Largest value of regional maximum thickness
    Median of regional maximum thickness
    Measurements on Average length of networks (units of connected segments)
    skeleton of extracted Maximum length of networks
    structures Average thickness of structure units (average distance
    transform values along skeleton)
    Maximum thickness of structure units (maximum distance
    transform values along skeleton)
    Number of nodes normalized by ROI area
    Number of segments normalized by ROI area
    Number of free-end segments normalized by ROI area
    Number of inner (node-to-node) segments normalized ROI area
    Average segment lengths
    Average free-end segment lengths
    Average inner segment lengths
    Average orientation angle of segments
    Average orientation angle of inner segments
    Segment tortuosity; a measure of straightness
    Segment solidity; another measure of straightness
    Average thickness of segments (average distance transform
    values along skeleton segments)
    Average thickness of free-end segments
    Average thickness of inner segments
    Ratio of inner segment lengths to inner segment thickness
    Ratio of free-end segment lengths to free-end segment thickness
    Interconnectivity index; a function of number of inner segments,
    free-end segments and number of networks.
    Directional skeleton All measurement of skeleton segments can be constrained by
    segment one or more desired orientation by measuring only skeleton
    measurements segments within ranges of angle.
    Watershed Watershed segmentation is applied to gray level images.
    segmentation Statistics of watershed segments are:
    Total area of segments
    Number of segments normalized by total area of segments
    Average area of segments
    Standard deviation of segment area
    Smallest segment area
    Largest segment area
  • As noted above, analysis can also include one or more additional techniques include, for example, Hough transform, mean pixel intensity analysis, variance of pixel intensity analysis, soft tissue analysis and the like. See, e.g., co-owned International Application WO 02/30283.
  • Calibrated density typically refers to the measurement of intensity values of features in images converted to its actual material density or expressed as the density of a reference material whose density is known. The reference material can be metal, polymer, plastics, bone, cartilage, etc., and can be part of the object being imaged or a calibration phantom placed in the imaging field of view during image acquisition.
  • Extracted structures typically refer to simplified or amplified representations of features derived from images. An example would be binary images of trabecular patterns generated by background subtraction and thresholding. Another example would be binary images of cortical bone generated by applying an edge filter and thresholding. The binary images can be superimposed on gray level images to generate gray level patterns of structure of interest.
  • Distance transform typically refers to an operation applied on binary images where maps representing distances of each 0 pixel to the nearest 1 pixel are generated. Distances can be calculated by the Euclidian magnitude, city-block distance, La Place distance or chessboard distance.
  • Distance transform of extracted structures typically refer to distance transform operation applied to the binary images of extracted structures, such as those discussed above with respect to calibrated density.
  • Skeleton of extracted structures typically refer to a binary image of 1 pixel wide patterns, representing the centerline of extracted structures. It is generated by applying a skeletonization or medial transform operation, by mathematical morphology or other methods, on an image of extracted structures.
  • Skeleton segments typically are derived from skeleton of extracted structures by performing pixel neighborhood analysis on each skeleton pixel. This analysis classifies each skeleton pixel as a node pixel or a skeleton segment pixel. A node pixel has more than 2 pixels in its 8-neighborhood. A skeleton segment is a chain of skeleton segment pixels continuously 8-connected. Two skeleton segments are separated by at least one node pixel.
  • Watershed segmentation as it is commonly known to a person of skill in the art, typically is applied to gray level images to characterize gray level continuity of a structure of interest. The statistics of dimensions of segments generated by the process are, for example, those listed in Table 3 above. As will be appreciated by those of skill in the art, however, other processes can be used without departing from the scope of the invention.
  • Turning now to FIG. 3A, a cross-section of a cartilage defect is shown 300. The cross-hatched zone 302 corresponds to an area where there is cartilage loss. FIG. 3B is a top view of the cartilage defect shown in FIG. 3A.
  • FIG. 3C illustrates the depth of a cartilage defect 310 in a first cross-section dimension with a dashed line illustrating a projected location of the original cartilage surface 312. By comparing these two values a ratio of cartilage defect depth to cartilage defect width can be calculated.
  • FIG. 3D illustrated the depth of the cartilage 320 along with the width of the cartilage defect 322. These two values can be compared to determine a ratio of cartilage depth to cartilage defect width.
  • FIG. 3E shows the depth of the cartilage defect 310 along with the depth of the cartilage 320. A dashed line is provided illustrating a projected location for the original cartilage surface 312. Similar to the measurements made above, ratios between the various measurements can be calculated.
  • Turning now to FIG. 3F, an area of bone marrow edema is shown on the femur 330 and the tibia 332. The shaded area of edema can be measured on a T2-weighted MRI scan. Alternatively, the area can be measured on one or more slices. These measurements can then be extended along the entire joint using multiple slices or a 3D acquisition. From these measurements volume can be determined or derived.
  • FIG. 3G shows an area of subchondral sclerosis in the acetabulum 340 and the femur 342. The sclerosis can be measured on, for example, a T1 or T2-weighted MRI scan or on a CT scan. The area can be measured on one or more slices. Thereafter the measurement can be extended along the entire joint using multiple slices or a 3D acquisition. From these values a volume can be derived of the subchondral sclerosis. For purposes of illustration, a single sclerosis has been shown on each surface. However, a person of skill in the art will appreciate that more than one sclerosis can occur on a single joint surface.
  • FIG. 3H shows osteophytes on the femur 350 and the tibia 352. The osteophytes are shown as cross-hatched areas. Similar to the sclerosis shown in FIG. 3G, the osteophytes can be measured on, for example, a T1 or T2-weighted MRI scan or on a CT scan. The area can be measured on one or more slices. Thereafter the measurement can be extended along the entire joint using multiple slices or a 3D acquisition. From these values a volume can be derived of the osteophytes. Additionally, a single osteophyte 354 or osteophyte groups 356 can be included in any measurement. Persons of skill in the art will appreciate that groups can be taken from a single joint surface or from opposing joint surfaces, as shown, without departing from the scope of the invention.
  • Turning now to FIG. 31 an area of subchondral cysts 360, 362, 364 is shown. Similar to the sclerosis shown in FIG. 3G, the cysts can be measured on, for example, a T1 or T2-weighted MRI scan or on a CT scan. The area can be measured on one or more slices. Thereafter the measurement can be extended along the entire joint using multiple slices or a 3D acquisition. From these values a volume can be derived of the cysts. Additionally, single cysts 366 or groups of cysts 366′ can be included in any measurement. Persons of skill in the art will appreciate that groups can be taken from a single joint surface, as shown, or from opposing joint surfaces without departing from the scope of the invention.
  • FIG. 3J illustrates an area of torn meniscal tissue (cross-hatched) 372, 374 as seen from the top 370 and in cross-section 371. Again, similar to the sclerosis shown in FIG. 3G, the torn meniscal tissue can be measured on, for example, a T1 or T2-weighted MRI scan or on a CT scan. The area can be measured on one or more slices. Thereafter the measurement can be extended along the entire joint using multiple slices or a 3D acquisition. From these values a volume can be derived of the tear. Ratios such as surface or volume of torn to normal meniscal tissue can be derived as well as ratios of surface of torn meniscus to surface of opposing articulating surface.
  • As shown in FIG. 4A, the process of optionally locating a ROI 100, extracting image data from the ROI 102, and deriving quantitative and/or qualitative image data from the extracted image data 120, can be repeated 122. Alternatively, or in addition, the process of locating a ROI 100, can be repeated 124. A person of skill in the art will appreciate that these steps can be repeated one or more times in any appropriate sequence, as desired, to obtain a sufficient amount of quantitative and/or qualitative data on the ROI or to separately extract or evaluate parameters. Further, the ROI used can be the same ROI as used in the first process or a newly identified ROI in the image. Additionally, as with FIG. 1A the steps of locating a region of interest 100, obtaining image data 102, and deriving quantitative and/or qualitative image data can be repeated one or more times, as desired, 101, 103, 121, respectively. Although not depicted here, as discussed above with respect to FIG. 1A, the additional step of locating a part of the body for study 98 can be performed prior to locating a region of interest 100 without departing from the invention. Additionally that step can be repeated 99.
  • FIG. 4B illustrates the process shown in FIG. 4A with the additional step enhancing image data 104. Additionally, the step of enhancing image data 104 can be repeated one or more times 105, as desired. The process of enhancing image data 104 can be repeated 126 one or more times as desired.
  • Turning now to FIG. 5A, a process is shown whereby a region of interest is optionally located 100. Although not depicted here, as discussed above with respect to FIG. 1A, the step of locating a part of the body for study 98 can be performed prior to locating a region of interest 100 without departing from the invention. Additionally that step can be repeated 99. Once the region of interest is located 100, and image data is extracted from the ROI 102, the extracted image data can then be converted to a 2D pattern 130, a 3D pattern 132 or a 4D pattern 133, for example including velocity or time, to facilitate data analyses. Following conversion to 2D 130, 3D 132 or 4D pattern 133 the images are evaluated for patterns 140. Additionally images can be converted from 2D to 3D 131, or from 3D to 4D 131′, if desired. Although not illustrated to avoid obscuring the figure, persons of skill in the art will appreciate that similar conversions can occur between 2D and 4D in this process or any process illustrated in this invention.
  • As will be appreciated by those of skill in the art, the conversion step is optional and the process can proceed directly from extracting image data from the ROI 102 to evaluating the data pattern 140 directly 134. Evaluating the data for patterns, includes, for example, performing the measurements described in Table 1 ,Table 2 or Table 3, above.
  • Additionally, the steps of locating the region of interest 100, obtaining image data 102, and evaluating patterns 141 can be performed once or a plurality of times, 101, 103, 141, respectively at any stage of the process. As will be appreciated by those of skill in the art, the steps can be repeated. For example, following an evaluation of patterns 140, additional image data can be obtained 135, or another region of interest can be located 137. These steps can be repeated as often as desired, in any combination desirable to achieve the data analysis desired.
  • FIG. 5B illustrates an alternative process to that shown in FIG. 5A which 5A THAT includes the step of enhancing image data 104 prior to converting an image or image data to a 2D 130, 3D 132, or 4D 133 pattern. The process of enhancing image data 104, can be repeated 105 if desired. FIG. 5C illustrates an alternative embodiment to the process shown in FIG. 5B. In this process, the step of enhancing image data 104 occurs after converting an image or image data to a 2D 130, 3D 132, or 4D 133 pattern. Again, the process of enhancing image data 104, can be repeated 105 if desired.
  • FIG. 5D illustrates an alternative process to that shown in FIG. 5A. After locating a part of the body for study 98 and imaging, the image is then converted to a 2D pattern 130, 3D pattern 132 or 4D pattern 133. The region of interest 100 is optionally located within the image after conversion to a 2D, 3D or 4D image and data is then extracted 102. Patterns are then evaluated in the extracted image data 140. As with the process of FIG. 5A, the conversion step is optional. Further, if desired, images can be converted between 2D, 3D 131 and 4D 131′ if desired.
  • Similar to FIG. 5A, some or all the processes can be repeated one or more times as desired. For example, locating a part of the body for study 98, locating a region of interest 100, obtaining image data 102, and evaluating patterns 140, can be repeated one or more times if desired, 99, 101, 103, 141, respectively. Again steps can be repeated. For example, following an evaluation of patterns 140, additional image data can be obtained 135, or another region of interest can be located 137 and/or another portion of the body can be located for study 139. These steps can be repeated as often as desired, in any combination desirable to achieve the data analysis desired.
  • FIG. 5E illustrates an alternative process to that shown in FIG. 5D. In this process image data can be enhanced 104. The step of enhancing image data can occur prior to conversion 143, prior to locating a region of interest 145, prior to obtaining image data 102, or prior to evaluating patterns 149.
  • Similar to FIG. 5A, some or all the processes can be repeated one or more times as desired, including the process of enhancing image data 104, which is shown as 105.
  • The method also comprises obtaining an image of a bone or a joint, optionally converting the image to a two-dimensional or three-dimensional or four-dimensional pattern, and evaluating the amount or the degree of normal, diseased or abnormal tissue or the degree of degeneration in a region or a volume of interest using one or more of the parameters specified in Table 1, Table 2 and/or Table 3. By performing this method at an initial time T1, information can be derived that is useful for diagnosing one or more conditions or for staging, or determining, the severity of a condition. This information can also be useful for determining the prognosis of a patient, for example with osteoporosis or arthritis. By performing this method at an initial time T1, and a later time T2, the change, for example in a region or volume of interest, can be determined which then facilitates the evaluation of appropriate steps to take for treatment. Moreover, if the subject is already receiving therapy or if therapy is initiated after time T1, it is possible to monitor the efficacy of treatment. By performing the method at subsequent times, T2-Tn. additional data ca be acquired that facilitate predicting the progression of the disease as well as the efficacy of any interventional steps that have been taken. As will be appreciated by those of skill in the art, subsequent measurements can be taken at regular time intervals or irregular time intervals, or combinations thereof. For example, it can be desirable to perform the analysis at T1 with an initial follow-up, T2, measurement taken one month later. The pattern of one month follow-up measurements could be performed for a year (12 one-month intervals) with subsequent follow-ups performed at 6 month intervals and then 12 month intervals. Alternatively, as an example, three initial measurements could be at one month, followed by a single six month follow up which is then followed again by one or more one month follow-ups prior to commencing 12 month follow ups. The combinations of regular and irregular intervals are endless, and are not discussed further to avoid obscuring the invention.
  • Moreover, one or more of the parameters listed in Tables 1, 2 and 3 can be measured. The measurements can be analyzed separately or the data can be combined, for example using statistical methods such as linear regression modeling or correlation. Actual and predicted measurements can be compared and correlated. See, also, Example 1.
  • The method for assessing the condition of a bone or joint in a subject can be fully automated such that the measurements of one or more of the parameters specified in Table 1, Table 2 or Table 3 are done automatically without intervention. The automatic assessment then can include the steps of diagnosis, staging, prognostication or monitoring the disease or diseases, or to monitor therapy. As will be appreciated by those of skill in the art, the fully automated measurement is, for example, possible with image processing techniques such as segmentation and registration. This process can include, for example, seed growing, thresholding, atlas and model based segmentation methods, live wire approaches, active and/or deformable contour approaches, contour tracking, texture based segmentation methods, rigid and non-rigid surface or volume registration, for example based on mutual information or other similarity measures. One skilled in the art will readily recognize other techniques and methods for fully automated assessment of the parameters and measurements specified in Table 1, Table 2 and Table 3.
  • Alternatively, the method of assessing the condition of a bone or joint in a subject can be semi-automated such that the measurements of one or more of the parameters, such as those specified in Table 1, are performed semi-automatically, i.e., with intervention. The semi-automatic assessment then allows for human interaction and, for example, quality control, and utilizing the measurement of said parameter(s) to diagnose, stage, prognosticate or monitor a disease or to monitor a therapy. The semi-automated measurement is, for example, possible with image processing techniques such as segmentation and registration. This can include seed growing, thresholding, atlas and model based segmentation methods, live wire approaches, active and/or deformable contour approaches, contour tracking, texture based segmentation methods, rigid and non-rigid surface or volume registration, for example base on mutual information or other similarity measures. One skilled in the art will readily recognize other techniques and methods for semi-automated assessment of the parameters specified in Table 1, Table 2 or Table 3.
  • Turning now to FIG. 6A, a process is shown whereby the user locates a ROI 100, extracts image data from the ROI 102, and then derives quantitative and/or qualitative image data from the extracted image data 120, as shown above with respect to FIG. 1. Following the step of deriving quantitative and/or qualitative image data, a candidate agent is administered to the patient 150. The candidate agent can be any agent the effects of which are to be studied. Agents can include any substance administered or ingested by a subject, for example, molecules, pharmaceuticals, biopharmaceuticals, agropharmaceuticals, or combinations thereof, including cocktails, that are thought to affect the quantitative and/or qualitative parameters that can be measured in a region of interest. These agents are not limited to those intended to treat disease that affects the musculoskeletal system but this invention is intended to embrace any and all agents regardless of the intended treatment site. Thus, appropriate agents are any agents whereby an effect can be detected via imaging. The steps of locating a region of interest 100, obtaining image data 102, obtaining quantitative and/or qualitative data from image data 120, and administering a candidate agent 150, can be repeated one or more times as desired, 101, 103, 121, 151, respectively.
  • FIG. 6B shows the additional step of enhancing image data 104, which can also be optionally repeated 105 as often as desired.
  • As shown in FIG. 6C these steps can be repeated one or more times 152 to determine the effect of the candidate agent. As will be appreciated by those of skill in the art, the step of repeating can occur at the stage of locating a region of interest 152 as shown in FIG. 6B or it can occur at the stage obtaining image data 153 or obtaining quantitative and/or qualitative data from image data 154 as shown in FIG. 6D.
  • FIG. 6E shows the additional step of enhancing image data 104, which can optionally be repeated 105, as desired.
  • As previously described, some or all the processes shown in FIGS. 6A-E can be repeated one or more times as desired. For example, locating a region of interest 100, obtaining image data 102, enhancing image data 104, obtaining quantitative and/or qualitative data 120, evaluating patterns 140, and administering candidate agent 150 can be repeated one or more times if desired, 101, 103, 105, 121, 141, 151 respectively.
  • In the scenario described in relation to FIGS. 6, an image is taken prior to administering the candidate agent. However, as will be appreciated by those of skill in the art, it is not always possible to have an image prior to administering the candidate agent. In those situations, progress is determined over time by evaluating the change in parameters from extracted image to extracted image.
  • Turning now to FIG. 7A, the process is shown whereby the candidate agent is administered first 150. Thereafter a region of interest is located in an image taken 100 and image data is extracted 102. Once the image data is extracted, quantitative and/or qualitative data is extracted from the image data 120. In this scenario, because the candidate agent is administered first, the derived quantitative and/or qualitative data derived is compared to a database 160 or a subset of the database, which database that, includes data for subjects having similar tracked parameters. As shown in FIG. 7B following the step of obtaining image data, the image data can be enhanced 104. This process can optionally be repeated 105, as desired.
  • Alternatively, as shown in FIG. 7C the derived quantitative and/or qualitative information can be compared to an image taken at T1 162, or any other time, if such image is available. As shown in FIG. 7D the step of enhancing image data 104 can follow the step of obtaining image data 102. Again, the process can be repeated 105, as desired.
  • As previously described, some or all the processes illustrated in FIGS. 7A-D can be repeated one or more times as desired. For example, locating a region of interest 100, obtaining image data 102, enhancing image data 104, obtaining quantitative and/or qualitative data 120, administering candidate agent 150, comparing quantitative and/or qualitative information to a database 160, comparing quantitative and/or qualitative information to an image taken at a prior time, such as T1, 162, monitoring therapy 170, monitoring disease progress 172, predicting disease course 174 can be repeated one or more times if desired, 101, 103, 105, 121, 151, 161, 163, 171, 173, 175 respectively. Each of these steps can be repeated in one or more loops as shown in FIG. 7B, 176, 177, 178, 179, 180, as desired or appropriate to enhance data collection.
  • Turning now to FIG. 8A, following the step of extracting image data from the ROI 102, the image can be transmitted 180. Transmission can be to another computer in the network or via the World Wide Web to another network. Following the step of transmitting the image 180, the image is converted to a pattern of normal and diseased tissue 190. Normal tissue includes the undamaged tissue located in the body part selected for study. Diseased tissue includes damaged tissue located in the body part selected for study. Diseased tissue can also include, or refer to, a lack of normal tissue in the body part selected for study. For example, damaged or missing cartilage would be considered diseased tissue. Once the image is converted, it is analyzed 200. FIG. 8B illustrates the process shown in FIG. 8A with the additional step of enhancing image data 104. As will be appreciated by those of skill in the art, this process can be repeated 105 as desired.
  • As shown in FIG. 8C, the step of transmitting the image 180 illustrated in FIG. 8A is optional and need not be practiced under the invention. As will be appreciated by those of skill in the art, the image can also be analyzed prior to converting the image to a pattern of normal and diseased. FIG. 8D illustrates the process shown in FIG. 8C with the additional step of enhancing image data 104 that is optionally repeated 105, as desired.
  • As previously described, some or all the processes in FIGS. 8A-D can be repeated one or more times as desired. For example, locating a region of interest 100, obtaining image data 102, enhancing image data 104, transmitting an image 180, converting the image to a pattern of normal and diseased 190, analyzing the converted image 200, can be repeated one or more times if desired, 101, 103, 105, 181, 191, 201 respectively.
  • FIG. 9 shows two devices 900, 920 that are connected. Either the first or second device can develop a degeneration pattern from an image of a region of interest 905. Similarly, either device can house a database for generating additional patterns or measurements 915. The first and second devices can communicate with each other in the process of analyzing an image, developing a degeneration pattern from a region of interest in the image, and creating a dataset of patterns or measurements or comparing the degeneration pattern to a database of patterns or measurements. However, all processes can be performed on one or more devices, as desired or necessary.
  • In this method the electronically generated, or digitized image or portions of the image can be electronically transferred from a transferring device to a receiving device located distant from the transferring device; receiving the transferred image at the distant location; converting the transferred image to a pattern of normal or diseased or abnormal tissue using one or more of the parameters specified in Table 1, Table 2 or Table 3; and optionally transmitting the pattern to a site for analysis. As will be appreciated by those of skill in the art, the transferring device and receiving device can be located within the same room or the same building. The devices can be on a peer-to-peer network, or an intranet. Alternatively, the devices can be separated by large distances and the information can be transferred by any suitable means of data transfer, including the World Wide Web and ftp protocols.
  • Alternatively, the method can comprise electronically transferring an electronically-generated image or portions of an image of a bone or a joint from a transferring device to a receiving device located distant from the transferring device; receiving the transferred image at the distant location; converting the transferred image to a degeneration pattern or a pattern of normal or diseased or abnormal tissue using one or more of the parameters specified in Table 1, Table 2 or Table 3; and optionally transmitting the degeneration pattern or the pattern of normal or diseased or abnormal tissue to a site for analysis.
  • Thus, the invention described herein includes methods and systems for prognosis of musculoskeletal disease, for example prognosis of fracture risk and the like. (See, also, Example 1). FIG. 10 is a schematic depiction of an image of a femur showing various ROIs that were analyzed to predict fracture risk based on assessment of one or more parameters shown in Tables 1, 2 and 3.
  • In order to make more accurate prognoses, it may be desirable in certain instances to compare data obtained from a subject to a reference database. For example, when predicting fracture risk, it may be useful to compile data of actual (known) fracture load in a variety of samples and store the results based on clinical risk factors such as age, sex and weight (or other characteristics) of the subject from which the sample is obtained. The images of these samples are analyzed to obtain parameters shown in Tables 1, 2 and 3. A fracture risk model correlated with fracture load may be developed using univariate, bivariate and/or multivariate statistical analysis of these parameters and is stored in this database. A fracture risk model may include information that is used to estimate fracture risk from parameters shown in Tables 1, 2 and 3. An example of a fracture risk model is the coefficients of a multivariate linear model derived from multivariate linear regression of these parameters (Tables 1,2,3, age, sex, weight, etc.) with fracture load. A person skilled in the art will appreciate that fracture risk models can be derived using other methods such as artificial neural networks and be represented by other forms such as the coefficients of artificial neural networks. Patient fracture risk can then be determined from measurements obtain from bone images by referencing to this database.
  • Methods of determining actual fracture load are known to those in the field. FIG. 11 is a schematic depiction of biomechanical testing of an intact femur. As shown, cross-sectional images may be taken throughout testing to determine at what load force a fracture occurs. FIG. 12B is a reproduction of an x-ray image depicting an example of an induced fracture in a fresh cadaveric femur.
  • The analysis techniques described herein can then be applied to a subject and the risk of fracture (or other disease) predicted using one or more of the parameters described herein. As shown in FIGS. 13 to 16, the prognostication methods described herein are as (or more) accurate than known techniques in predicting fracture risk. FIG. 13 is a graph depicting linear regression analysis of DXA bone mineral density correlated to fracture load. Correlations of individual parameters to fracture load are comparable to DXA (FIGS. 14 and 15). However, when multiple structural parameters are combined, the prediction of load at which fracture will occur is more accurate. (FIG. 16). Thus, the analyses of images as described herein can be used to accurately predict musculoskeletal disease such as fracture risk.
  • Another aspect of the invention is a kit for aiding in assessing the condition of a bone or a joint of a subject, which kit comprises a software program, which when installed and executed on a computer reads a degeneration pattern or a pattern of normal or diseased or abnormal tissue derived using one or more of the parameters specified in Table 1, Table 2 or Table 3 presented in a standard graphics format and produces a computer readout. The kit can further include a database of measurements for use in calibrating or diagnosing the subject. One or more databases can be provided to enable the user to compare the results achieved for a specific subject against, for example, a wide variety of subjects, or a small subset of subjects having characteristics similar to the subject being studied.
  • A system is provided that includes (a) a device for electronically transferring a degeneration pattern or a pattern of normal, diseased or abnormal tissue for the bone or the joint to a receiving device located distant from the transferring device; (b) a device for receiving said pattern at the remote location; (c) a database accessible at the remote location for generating additional patterns or measurements for the bone or the joint of the human wherein the database includes a collection of subject patterns or data, for example of human bones or joints, which patterns or data are organized and can be accessed by reference to characteristics such as type of joint, gender, age, height, weight, bone size, type of movement, and distance of movement; (d) optionally a device for transmitting the correlated pattern back to the source of the degeneration pattern or pattern of normal, diseased or abnormal tissue.
  • Thus, the methods and systems described herein make use of collections of data sets of measurement values, for example measurements of bone structure and/or bone mineral density from images (e.g., x-ray images). Records can be formulated in spreadsheet-like format, for example including data attributes such as date of image (x-ray), patient age, sex, weight, current medications, geographic location, etc. The database formulations can further comprise the calculation of derived or calculated data points from one or more acquired data points, typically using the parameters listed in Tables 1, 2 and 3 or combinations thereof. A variety of derived data points can be useful in providing information about individuals or groups during subsequent database manipulation, and are therefore typically included during database formulation. Derived data points include, but are not limited to the following: (1) maximum value, e.g. bone mineral density, determined for a selected region of bone or joint or in multiple samples from the same or different subjects; (2) minimum value, e.g. bone mineral density, determined for a selected region of bone or joint or in multiple samples from the same or different subjects; (3) mean value, e.g. bone mineral density, determined for a selected region of bone or joint or in multiple samples from the same or different subjects; (4) the number of measurements that are abnormally high or low, determined by comparing a given measurement data point with a selected value; and the like. Other derived data points include, but are not limited to the following: (1) maximum value of a selected bone structure parameter, determined for a selected region of bone or in multiple samples from the same or different subjects; (2) minimum value of a selected bone structure parameter, determined for a selected region of bone or in multiple samples from the same or different subjects; (3) mean value of a selected bone structure parameter, determined for a selected region of bone or in multiple samples from the same or different subjects; (4) the number of bone structure measurements that are abnormally high or low, determined by comparing a given measurement data point with a selected value; and the like. Other derived data points will be apparent to persons of ordinary skill in the art in light of the teachings of the present specification. The amount of available data and data derived from (or arrived at through analysis of) the original data provides an unprecedented amount of information that is very relevant to management of bone-related diseases such as osteoporosis. For example, by examining subjects over time, the efficacy of medications can be assessed.
  • Measurements and derived data points are collected and calculated, respectively, and can be associated with one or more data attributes to form a database. The amount of available data and data derived from (or arrived at through analysis of) the original data provide provides an unprecedented amount of information that is very relevant to management of musculoskeletal-related diseases such as osteoporosis or arthritis. For example, by examining subjects over time, the efficacy of medications can be assessed.
  • Data attributes can be automatically input with the electronic image and can include, for example, chronological information (e.g., DATE and TIME). Other such attributes can include, but are not limited to, the type of imager used, scanning information, digitizing information and the like. Alternatively, data attributes can be input by the subject and/or operator, for example subject identifiers, i.e. characteristics associated with a particular subject. These identifiers include but are not limited to the following: (1) a subject code (e.g., a numeric or alpha-numeric sequence); (2) demographic information such as race, gender and age; (3) physical characteristics such as weight, height and body mass index (BMI); (4) selected aspects of the subject's medical history (e.g., disease states or conditions, etc.); and (5) disease-associated characteristics such as the type of bone disorder, if any; the type of medication used by the subject. In the practice of the present invention, each data point would typically be identified with the particular subject, as well as the demographic, etc. characteristic of that subject.
  • Other data attributes will be apparent to persons of ordinary skill in the art in light of the teachings of the present specification. (See, also, WO 02/30283, incorporated by reference in its entirety herein).
  • Thus, data (e.g., bone structural information or bone mineral density information or articular information) is obtained from normal control subjects using the methods described herein. These databases are typically referred to as “reference databases” and can be used to aid analysis of any given subject's image, for example, by comparing the information obtained from the subject to the reference database. Generally, the information obtained from the normal control subjects will be averaged or otherwise statistically manipulated to provide a range of “normal” measurements. Suitable statistical manipulations and/or evaluations will be apparent to those of skill in the art in view of the teachings herein. The comparison of the subject's information to the reference database can be used to determine if the subject's bone information falls outside the normal range found in the reference database or is statistically significantly different from a normal control.
  • Data obtained from images, as described above, can be manipulated, for example, using a variety of statistical analyses to produce useful information. Databases can be created or generated from the data collected for an individual, or for a group of individuals, over a defined period of time (e.g., days, months or years), from derived data, and from data attributes.
  • For example, data can be aggregated, sorted, selected, sifted, clustered and segregated by means of the attributes associated with the data points. A number of data mining software exist which can be used to perform the desired manipulations.
  • Relationships in various data can be directly queried and/or the data analyzed by statistical methods to evaluate the information obtained from manipulating the database.
  • For example, a distribution curve can be established for a selected data set, and the mean, median and mode calculated therefor. Further, data spread characteristics, e.g., variability, quartiles, and standard deviations can be calculated.
  • The nature of the relationship between any variables of interest can be examined by calculating correlation coefficients. Useful methods for doing so include, but are not limited to: Pearson Product Moment Correlation and Spearman Rank Correlation. Analysis of variance permits testing of differences among sample groups to determine whether a selected variable has a discernible effect on the parameter being measured.
  • Non-parametric tests can be used as a means of testing whether variations between empirical data and experimental expectancies are attributable to chance or to the variable or variables being examined. These include the Chi Square test, the Chi Square Goodness of Fit, the 2×2 Contingency Table, the Sign Test and the Phi Correlation Coefficient. Other tests include z-scores, T-scores or lifetime risk for arthritis, cartilage loss or osteoporotic fracture.
  • There are numerous tools and analyses available in standard data mining software that can be applied to the analyses of the databases that can be created according to this invention. Such tools and analysis include, but are not limited to, cluster analysis, factor analysis, decision trees, neural networks, rule induction, data driven modeling, and data visualization. Some of the more complex methods of data mining techniques are used to discover relationships that are more empirical and data-driven, as opposed to theory driven, relationships.
  • Statistical significance can be readily determined by those of skill in the art. The use of reference databases in the analysis of images facilitates that diagnosis, treatment and monitoring of bone conditions such as osteoporosis.
  • For a general discussion of statistical methods applied to data analysis, see Applied Statistics for Science and Industry, by A. Romano, 1977, Allyn and Bacon, publisher.
  • The data is preferably stored and manipulated using one or more computer programs or computer systems. These systems will typically have data storage capability (e.g., disk drives, tape storage, optical disks, etc.). Further, the computer systems can be networked or can be stand-alone systems. If networked, the computer system would be able to transfer data to any device connected to the networked computer system for example a medical doctor or medical care facility using standard e-mail software, a central database using database query and update software (e.g., a data warehouse of data points, derived data, and data attributes obtained from a large number of subjects). Alternatively, a user could access from a doctor's office or medical facility, using any computer system with Internet access, to review historical data that can be useful for determining treatment.
  • If the networked computer system includes a World Wide Web application, the application includes the executable code required to generate database language statements, for example, SQL statements. Such executables typically include embedded SQL statements. The application further includes a configuration file that contains pointers and addresses to the various software entities that are located on the database server in addition to the different external and internal databases that are accessed in response to a user request. The configuration file also directs requests for database server resources to the appropriate hardware, as can be necessary if the database server is distributed over two or more different computers.
  • As a person of skill in the art will appreciate, one or more of the parameters specified in Table 1, Table and Table 3 can be used at an initial time point T1 to assess the severity of a bone disease such as osteoporosis or arthritis. The patient can then serve as their own control at a later time point T2, when a subsequent measurement using one or more of the same parameters used at T1 is repeated.
  • A variety of data comparisons can be made that will facilitate drug discovery, efficacy, dosing, and comparisons. For example, one or more of the parameters specified in Table 1, Table 2 and Table 3 may be used to identify lead compounds during drug discovery. For example, different compounds can be tested in animal studies and the lead compounds with regard to highest therapeutic efficacy and lowest toxicity, e.g. to the bone or the cartilage, can be identified. Similar studies can be performed in human subjects, e. g. FDA phase I, II or III trials. Alternatively, or in addition, one or more of the parameters specified in Table 1, Table 2 and Table 3 can be used to establish optimal dosing of a new compound. It will be appreciated also that one or more of the parameters specified in Table 1, Table 2 and Table 3 can be used to compare a new drug against one or more established drugs or a placebo. The patient can then serve as their own control at a later time point T2,
  • EXAMPLES Example 1 Correlation of Macro-Anatomical and Structural Parameters to Fracture Load
  • Using 15 fresh cadaveric femurs, the following analyses were performed to determine the correlation of macro-anatomical and structural parameters to fracture load.
  • Standardization of Hip radiographs: Density and magnification calibration on the x-ray radiographs was achieved using a calibration phantom. The reference orientation of the hip x-rays was the average orientation of the femoral shaft.
  • Automatic Placement of Regions of Interest. An algorithm was developed and used to consistently and accurately place 7 regions of interest based on the geometric and position of proximal femur. FIG. 10. In brief, the algorithm involved the detection of femoral boundaries, estimation of shaft and neck axes, and construction of ROI based on axes and boundary intercept points. This approach ensured that the size and shape of ROIs placed conformed to the scale and shape of the femur, and thus were consistent relative to anatomic features on the femur.
  • Automatic Segmentation of the proximal femur: A global gray level thresholding using bi-modal histogram segmentation algorithm(s) was performed on the hip images and a binary image of the proximal femur was generated. Edge-detection analysis was also performed on the hip x-rays, including edge detection of the outline of the proximal femur that involved breaking edges detected into segments and characterizing the orientation of each segment. Each edge segment was then referenced to a map of expected proximal femur edge orientation and to a map of the probability of edge location. Edge segments that did not conform to the expected orientation or which were in low probability regions were removed. Morphology operations were applied to the edge image(s) to connect any discontinuities. The edge image formed an enclosed boundary of the proximal femur. The region within the boundary was then combined with the binary image from global thresholding to form the final mask of the proximal femur.
  • Automatic Segmentation and Measurement of the Femoral Cortex: Within a region of interest (ROI), edge detection was applied. Morphology operations were applied to connect edge discontinuities. Segments were formed within enclosed edges. The area and the major axis length of each segment were then measured. The regions were also superimposed on the original gray level image and average gray level within each region was measured. The cortex was identified as those segments connected to the boundary of the proximal femur mask with the greatest area, longest major axis length and a mean gray level about the average gray level of all enclosed segments within the proximal femur mask.
  • The segment identified as cortex was then skeletonized. The orientation of the cortex skeleton was verified to conform to the orientation map of the proximal femur edge. Euclidean distance transform was applied to the binary image of the segment. The values of distance transform value along the skeleton were sampled and their average, standard deviation, minimum, maximum and mod determined.
  • Watershed Segmentation for Characterizing Trabecular Structure: Marrow spacing was characterized by determining watershed segmentation of gray level trabecular structures on the hip images; essentially as described in Russ “The Image Processing Handbook,” 3rd. ed. pp. 494-501. This analysis take the gray level contrast between the marrow spacing and adjacent trabecular structures into account. The segments of marrow spacing generated using watershed segmentation were measured for the area, eccentricity, orientation, and the average gray level on the x-ray image within the segment. Mean, standard deviation, minimum, maximum and mod. were determined for each segment. In addition, various structural and/or macro-anatomical parameters were assessed for several ROIs (FIG. 10).
  • Measurement of Femoral Neck BMD: DXA analysis of bone mineral density was performed in the femoral neck region of the femurs.
  • Biomechanical Testing of Intact Femur Each cadaveric femur sample (n=15) was tested for fracture load as follows. First, the femur was placed at a 15° angle of tilt and an 8° external rotation in an Instron 1331 Instrument (Instron, Inc.) and a load vector at the femoral head simulating single-leg stance was generated, essentially as described in Cheal et al. (1992) J. Orthop. Res. 10(3):405-422. Second, varus/valgus and torsional resistive movements simulating passive knee ligaments restraints were applied. Next, forces and movement at failure were measured using a six-degree of freedom load cell. Subsequently, a single ramp, axial compressive load was applied to the femoral head of each sample at 100 mm/s until fracture. (FIG. 12). Fracture load and resultant equilibrium forces and moments at the distal end of the femur were measured continuously. FIG. 11 shows various results of biomechanical testing.
  • The correlation between (1) DXA femoral next BMD and facture load; (2) bone structure and fracture load; and (3) macro-anatomical analyses and fracture load was determined and shown in FIG. 13-15, respectively.
  • Multivariate linear regression analysis was also performed, combining several structural and macro-anatomical parameters, including local maximum marrow spacing (r=0.6 linearized); standard deviation of cortical thickness of RO13 (r=0.57); maximum cortical thickness of RO15 (r=0.56); and mean node-free end length for RO13 (r=0.50). Results are shown in FIG. 16 and demonstrate that, using analyses, described herein there is a good correlation between predicted fracture load and actual fracture load (r=0.81, p<0.001). The mean fracture load was 5.4 kiloNewton with a standard deviation of 2.3 kiloNewton. These statistics and the coefficients of multivariate linear regression were stored as data of the fracture load reference database.
  • Example 2 Correlation of 2D and 3D Measurements
  • To demonstrate that methods using 2D x-ray technology to quantitatively assess trabecular architecture is as effective as 3D μ CT, which serves as a gold standard for such measurements, the following experiments were performed. Bone cores (n=48) were harvested from cadaveric proximal femora. Specimen radiographs were obtained and 2D structural parameters were measured on the radiographs. Cores were then subjected to 3D μCT and biomechanical testing. The μCT images were analyzed to obtained 3D micro-structural measurements. Digitized 2D x-ray images of these cores were also analyzed as described herein to obtain comparative micro-structural measurements.
  • Results showed very good correlation among the numerous 2D parameters and 3D μCT measurements, including for example correlation between 2D Trabecular Perimeter/Trabecular Area (Tb.P/Tb.A) with 3D Bone Surface/Bone Volume (r=0.92, p<0.001), and 2D Trabecular Separation (Tb.Sp) with 3D Trabecular Separation (r=0.88, p<0.001). The 2D Tb. P/Tb.A and 2D Tb.Sp also function correlate very well as predictive parameters for the mechanical loads required to fracture the cores, with r=−0.84 (p<0.001) and r=−0.83 (p<0.001), respectively, when logarithmic and exponential transformations were used in the regression.
  • These results demonstrate that 2D micro-structural measurements of trabecular bone from digitized radiographs are highly correlated with 3D measurements obtained from μ-CT images. Therefore, the mechanical characteristics of trabecular bone microstructure from digitized radiographic images can be accurately determined from 2D images.
  • Example 3 Prediction of Fracture Risk using Fracture Load Reference Database
  • A hip x-ray of cadaver pelvis was exposed using standard clinical procedure and equipment. The radiograph film was developed and digitized. The image was then analyzed to obtain micro-structure, and macro-anatomical parameters. The local maximum spacing, standard deviation of cortical thickness of RO13, maximum cortical thickness of RO15, and mean node-free end length for RO13 were used to predict load required to fracture the cadaver hip using the coefficients of multivariate linear regression stored in the fracture load reference database. The predicted fracture load was 7.5 kiloNewton. This fracture load is 0.98 standard deviation above the average of the fracture load reference database (or z-score=0.98). This result may suggest that the subject had a relatively low risk of sustaining a hip fracture as compared to the population of the reference database.
  • The foregoing description of embodiments of the present invention has been provided for the purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise forms disclosed. Many modifications and variations will be apparent to the practitioner skilled in the art. The embodiments were chosen and described in order to best explain the principles of the invention and its practical application, thereby enabling others skilled in the art to understand the invention and the various embodiments and with various modifications that are suited to the particular use contemplated. It is intended that the scope of the invention be defined by the following claims and its equivalence.

Claims (1)

What is claimed is:
1. A method for generating, in a computer system, a parameter map from a bone image of a subject, the method comprising:
(a) obtaining the bone image of the subject;
(b) defining two or more regions of interest (ROIs) in the image;
(c) analyzing a plurality of positions in the ROIs to obtain measurements for one or more bone microarchitecture parameters and one or more bone macro-anatomy parameters; and
(d) generating the parameter map from the measurements.
US14/462,760 2002-09-16 2014-08-19 Methods of Predicting Musculoskeletal Disease Abandoned US20140355852A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US14/462,760 US20140355852A1 (en) 2002-09-16 2014-08-19 Methods of Predicting Musculoskeletal Disease
US15/809,366 US20180330499A1 (en) 2002-09-16 2017-11-10 Methods of Predicting Musculoskeletal Disease
US16/289,054 US20190370961A1 (en) 2002-09-16 2019-02-28 Methods of Predicting Musculoskeletal Disease

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US41141302P 2002-09-16 2002-09-16
US43864103P 2003-01-07 2003-01-07
US10/665,725 US20040106868A1 (en) 2002-09-16 2003-09-16 Novel imaging markers in musculoskeletal disease
US10/753,976 US7840247B2 (en) 2002-09-16 2004-01-07 Methods of predicting musculoskeletal disease
US12/948,276 US8818484B2 (en) 2002-09-16 2010-11-17 Methods of predicting musculoskeletal disease
US14/462,760 US20140355852A1 (en) 2002-09-16 2014-08-19 Methods of Predicting Musculoskeletal Disease

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US12/948,276 Continuation US8818484B2 (en) 2002-09-16 2010-11-17 Methods of predicting musculoskeletal disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/809,366 Continuation US20180330499A1 (en) 2002-09-16 2017-11-10 Methods of Predicting Musculoskeletal Disease

Publications (1)

Publication Number Publication Date
US20140355852A1 true US20140355852A1 (en) 2014-12-04

Family

ID=46300651

Family Applications (5)

Application Number Title Priority Date Filing Date
US10/753,976 Active 2025-11-23 US7840247B2 (en) 2002-09-16 2004-01-07 Methods of predicting musculoskeletal disease
US12/948,276 Expired - Lifetime US8818484B2 (en) 2002-09-16 2010-11-17 Methods of predicting musculoskeletal disease
US14/462,760 Abandoned US20140355852A1 (en) 2002-09-16 2014-08-19 Methods of Predicting Musculoskeletal Disease
US15/809,366 Abandoned US20180330499A1 (en) 2002-09-16 2017-11-10 Methods of Predicting Musculoskeletal Disease
US16/289,054 Abandoned US20190370961A1 (en) 2002-09-16 2019-02-28 Methods of Predicting Musculoskeletal Disease

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US10/753,976 Active 2025-11-23 US7840247B2 (en) 2002-09-16 2004-01-07 Methods of predicting musculoskeletal disease
US12/948,276 Expired - Lifetime US8818484B2 (en) 2002-09-16 2010-11-17 Methods of predicting musculoskeletal disease

Family Applications After (2)

Application Number Title Priority Date Filing Date
US15/809,366 Abandoned US20180330499A1 (en) 2002-09-16 2017-11-10 Methods of Predicting Musculoskeletal Disease
US16/289,054 Abandoned US20190370961A1 (en) 2002-09-16 2019-02-28 Methods of Predicting Musculoskeletal Disease

Country Status (1)

Country Link
US (5) US7840247B2 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9155501B2 (en) 2003-03-25 2015-10-13 Imatx, Inc. Methods for the compensation of imaging technique in the processing of radiographic images
US9267955B2 (en) 2001-05-25 2016-02-23 Imatx, Inc. Methods to diagnose treat and prevent bone loss
US9275469B2 (en) 2000-10-11 2016-03-01 Imatx, Inc. Methods and devices for evaluating and treating a bone condition on x-ray image analysis
US9460506B2 (en) 2002-09-16 2016-10-04 Imatx, Inc. System and method for predicting future fractures
US20170098315A1 (en) * 2015-10-06 2017-04-06 Rigaku Corporation Analyzer, analysis method and analysis program of bone mineral density
US9737406B2 (en) 2013-08-21 2017-08-22 Laboratories Bodycad Inc. Anatomically adapted orthopedic implant and method of manufacturing same
US9767551B2 (en) 2000-10-11 2017-09-19 Imatx, Inc. Methods and devices for analysis of x-ray images
USD808524S1 (en) 2016-11-29 2018-01-23 Laboratoires Bodycad Inc. Femoral implant
WO2018204404A1 (en) * 2017-05-01 2018-11-08 Rhode Island Hospital Non-invasive measurement to predict post-surgery anterior cruciate ligament success
US10667829B2 (en) 2013-08-21 2020-06-02 Laboratoires Bodycad Inc. Bone resection guide and method
US20200170604A1 (en) * 2018-12-04 2020-06-04 Howmedica Osteonics Corp. CT Based Probabilistic Cancerous Bone Region Detection

Families Citing this family (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE439806T1 (en) 1998-09-14 2009-09-15 Univ Leland Stanford Junior DETERMINING THE CONDITION OF A JOINT AND PREVENTING DAMAGE
US7239908B1 (en) 1998-09-14 2007-07-03 The Board Of Trustees Of The Leland Stanford Junior University Assessing the condition of a joint and devising treatment
US7184814B2 (en) 1998-09-14 2007-02-27 The Board Of Trustees Of The Leland Stanford Junior University Assessing the condition of a joint and assessing cartilage loss
US6904123B2 (en) 2000-08-29 2005-06-07 Imaging Therapeutics, Inc. Methods and devices for quantitative analysis of x-ray images
US20020186818A1 (en) * 2000-08-29 2002-12-12 Osteonet, Inc. System and method for building and manipulating a centralized measurement value database
US7050534B2 (en) * 2000-08-29 2006-05-23 Imaging Therapeutics, Inc. Methods and devices for quantitative analysis of x-ray images
US7467892B2 (en) * 2000-08-29 2008-12-23 Imaging Therapeutics, Inc. Calibration devices and methods of use thereof
JP4049312B2 (en) * 2000-08-29 2008-02-20 イメージング セラピューティクス,インコーポレーテッド X-ray image quantitative analysis method and apparatus
ATE426357T1 (en) 2000-09-14 2009-04-15 Univ Leland Stanford Junior ASSESSING THE CONDITION OF A JOINT AND PLANNING TREATMENT
US20070047794A1 (en) * 2000-10-11 2007-03-01 Philipp Lang Methods and devices for analysis of x-ray images
JP2003320064A (en) * 2002-05-07 2003-11-11 Konami Sports Life Corp Exercise support system
US7840247B2 (en) 2002-09-16 2010-11-23 Imatx, Inc. Methods of predicting musculoskeletal disease
JP2006512938A (en) * 2002-09-16 2006-04-20 イメージング セラピューティクス,インコーポレーテッド Imaging markers for musculoskeletal diseases
US8290564B2 (en) 2003-09-19 2012-10-16 Imatx, Inc. Method for bone structure prognosis and simulated bone remodeling
AU2004274003A1 (en) 2003-09-19 2005-03-31 Imaging Therapeutics, Inc. Method for bone structure prognosis and simulated bone remodeling
JP4848369B2 (en) 2004-06-18 2011-12-28 インぺディメッド リミテッド Apparatus and method for operating edema detection
CA2580726A1 (en) 2004-09-16 2006-03-30 Imaging Therapeutics, Inc. System and method of predicting future fractures
WO2006054194A2 (en) * 2004-11-22 2006-05-26 Koninklijke Philips Electronics, N.V. Improved data representation for rtp
US8182422B2 (en) 2005-12-13 2012-05-22 Avantis Medical Systems, Inc. Endoscope having detachable imaging device and method of using
US8872906B2 (en) 2005-01-05 2014-10-28 Avantis Medical Systems, Inc. Endoscope assembly with a polarizing filter
US8289381B2 (en) 2005-01-05 2012-10-16 Avantis Medical Systems, Inc. Endoscope with an imaging catheter assembly and method of configuring an endoscope
US8235887B2 (en) 2006-01-23 2012-08-07 Avantis Medical Systems, Inc. Endoscope assembly with retroscope
US8797392B2 (en) 2005-01-05 2014-08-05 Avantis Medical Sytems, Inc. Endoscope assembly with a polarizing filter
US20070015989A1 (en) * 2005-07-01 2007-01-18 Avantis Medical Systems, Inc. Endoscope Image Recognition System and Method
WO2007002993A1 (en) 2005-07-01 2007-01-11 Impedimed Limited Monitoring system
US8548580B2 (en) 2005-07-01 2013-10-01 Impedimed Limited Monitoring system
EP1907055A2 (en) * 2005-07-14 2008-04-09 Koninklijke Philips Electronics N.V. Method of accounting for tumor motion in radiotherapy treatment
US8179440B2 (en) * 2005-12-05 2012-05-15 University Of Maryland Method and system for object surveillance and real time activity recognition
JP5106418B2 (en) * 2006-01-11 2012-12-26 デンシス エルティーディー. 3D modeling in the oral cavity
US8287446B2 (en) 2006-04-18 2012-10-16 Avantis Medical Systems, Inc. Vibratory device, endoscope having such a device, method for configuring an endoscope, and method of reducing looping of an endoscope
EP2023794A2 (en) 2006-05-19 2009-02-18 Avantis Medical Systems, Inc. System and method for producing and improving images
US8175349B2 (en) * 2006-08-16 2012-05-08 Siemens Medical Solutions Usa, Inc. System and method for segmenting vertebrae in digitized images
WO2008034101A2 (en) * 2006-09-15 2008-03-20 Imaging Therapeutics, Inc. Method and system for providing fracture/no fracture classification
AU2007327573B2 (en) * 2006-11-30 2013-07-18 Impedimed Limited Measurement apparatus
US8064666B2 (en) 2007-04-10 2011-11-22 Avantis Medical Systems, Inc. Method and device for examining or imaging an interior surface of a cavity
EP2148613B9 (en) 2007-04-20 2014-12-10 Impedimed Limited Monitoring system and probe
US20080260217A1 (en) * 2007-04-23 2008-10-23 Adi Mashiach System and method for designating a boundary of a vessel in an image
WO2009042644A2 (en) * 2007-09-25 2009-04-02 Perception Raisonnement Action En Medecine Methods and apparatus for assisting cartilage diagnostic and therapeutic procedures
US8235906B2 (en) * 2007-12-31 2012-08-07 The Brigham And Women's Hospital, Inc. System and method for accelerated focused ultrasound imaging
AU2008207672B2 (en) 2008-02-15 2013-10-31 Impedimed Limited Impedance Analysis
US8582843B2 (en) 2008-08-12 2013-11-12 Wyeth Pharmaceuticals, Inc. Morphometry of the human knee joint and prediction for osteoarthritis
WO2010018406A1 (en) * 2008-08-12 2010-02-18 Wyeth Pharmaceuticals Inc. Morphometry of the human hip joint and prediction of osteoarthritis
WO2010025131A1 (en) * 2008-08-27 2010-03-04 Tufts Medical Center Bone mineral density ratios as a predictor of osteoarthritis
EP2328476B1 (en) * 2008-09-19 2014-04-16 Duke University Systems and methods for generating an osteoarthritis progression predictor and systems and methods for using the predictor
US8649577B1 (en) * 2008-11-30 2014-02-11 Image Analysis, Inc. Automatic method and system for measurements of bone density and structure of the hip from 3-D X-ray imaging devices
JP2012516995A (en) 2009-02-02 2012-07-26 ネステク ソシエテ アノニム Method for diagnosing impending joint failure
US8939917B2 (en) 2009-02-13 2015-01-27 Imatx, Inc. Methods and devices for quantitative analysis of bone and cartilage
US20100222705A1 (en) * 2009-03-01 2010-09-02 Craig John J Method of measuring quality of the equine distal phallange from a lateral-medial radiograph
WO2011050393A1 (en) 2009-10-26 2011-05-05 Impedimed Limited Fluid level indicator determination
CA2778770A1 (en) 2009-11-18 2011-05-26 Chung Shing Fan Signal distribution for patient-electrode measurements
CN102740789A (en) 2009-11-20 2012-10-17 膝部创造物有限责任公司 Instruments for targeting a joint defect
US8821504B2 (en) 2009-11-20 2014-09-02 Zimmer Knee Creations, Inc. Method for treating joint pain and associated instruments
KR20120104580A (en) 2009-11-20 2012-09-21 니 크리에이션스, 엘엘씨 Navigation and positioning instruments for joint repair
US8951261B2 (en) 2009-11-20 2015-02-10 Zimmer Knee Creations, Inc. Subchondral treatment of joint pain
US8801800B2 (en) 2009-11-20 2014-08-12 Zimmer Knee Creations, Inc. Bone-derived implantable devices and tool for subchondral treatment of joint pain
WO2011063240A1 (en) 2009-11-20 2011-05-26 Knee Creations, Llc Implantable devices for subchondral treatment of joint pain
AU2010321743A1 (en) 2009-11-20 2012-07-12 Knee Creations, Llc Coordinate mapping system for joint treatment
JP2013511356A (en) 2009-11-20 2013-04-04 ニー・クリエイションズ・リミテッド・ライアビリティ・カンパニー Device for variable angle approach to joints
DK2539714T3 (en) * 2010-02-22 2019-04-08 Univ Duke BIOMARKERS OF MUSCLE AND BONE DISEASE
US8693634B2 (en) * 2010-03-19 2014-04-08 Hologic Inc System and method for generating enhanced density distribution in a three dimensional model of a structure for use in skeletal assessment using a limited number of two-dimensional views
JP5801577B2 (en) * 2010-03-25 2015-10-28 キヤノン株式会社 Optical tomographic imaging apparatus and control method for optical tomographic imaging apparatus
WO2012083136A1 (en) * 2010-12-17 2012-06-21 The Trustees Of Columbia University In The City Of New York Apparatus, method and computer-accessible medium for diagnosing and subtyping psychiatric diseases
US9036883B2 (en) 2011-01-10 2015-05-19 The Regents Of The University Of Michigan System and methods for detecting liver disease
ITPI20110054A1 (en) * 2011-05-16 2012-11-17 Echolight S R L ULTRASOUND APPARATUS TO ASSESS THE STATE OF THE BONE STRUCTURE OF A PATIENT
US9119646B2 (en) 2011-08-07 2015-09-01 Zimmer Knee Creations, Inc. Subchondral treatment to prevent the progression of osteoarthritis of the joint
US20140066767A1 (en) * 2012-08-31 2014-03-06 Clearview Diagnostics, Inc. System and method for noise reduction and signal enhancement of coherent imaging systems
ES2460415B8 (en) * 2012-11-12 2015-10-13 Grupo Hospitalario Quirón, S.A. PROCEDURE FOR THE CALCULATION OF A CARTÍLAGO DEGENERATION INDEX
US9514213B2 (en) * 2013-03-15 2016-12-06 Oracle International Corporation Per-attribute data clustering using tri-point data arbitration
JP6345178B2 (en) * 2013-07-23 2018-06-20 富士フイルム株式会社 Radiation image processing apparatus and method
US9848818B1 (en) * 2013-08-09 2017-12-26 O.N.Diagnostics, LLC Clinical assessment of fragile bone strength
US11850061B2 (en) * 2013-08-09 2023-12-26 O.N.Diagnostics, LLC Clinical assessment of fragile bone strength
US9089696B2 (en) * 2013-11-07 2015-07-28 Varian Medical Systems International Ag Time-resolved pre-treatment portal dosimetry systems, devices, and methods
JP5722414B1 (en) * 2013-11-25 2015-05-20 メディア株式会社 Osteoporosis diagnosis support device
CN103793908A (en) * 2014-01-17 2014-05-14 首都医科大学 Method for constructing prediction model of multifunctional veins based on brain nuclear magnetic resonance image
US9418415B2 (en) 2014-02-05 2016-08-16 Shimadzu Corporation Trabecular bone analyzer
US10588589B2 (en) 2014-07-21 2020-03-17 Zebra Medical Vision Ltd. Systems and methods for prediction of osteoporotic fracture risk
US10039513B2 (en) 2014-07-21 2018-08-07 Zebra Medical Vision Ltd. Systems and methods for emulating DEXA scores based on CT images
US11213220B2 (en) * 2014-08-11 2022-01-04 Cubisme, Inc. Method for determining in vivo tissue biomarker characteristics using multiparameter MRI matrix creation and big data analytics
WO2016127035A1 (en) 2015-02-05 2016-08-11 Duke University Methods of detecting osteoarthritis and predicting progression thereof
WO2016129682A1 (en) * 2015-02-13 2016-08-18 株式会社島津製作所 Bone analyzing device
US20160331339A1 (en) * 2015-05-15 2016-11-17 The Trustees Of Columbia University In The City Of New York Systems And Methods For Early Detection And Monitoring Of Osteoarthritis
US9922433B2 (en) 2015-05-29 2018-03-20 Moira F. Schieke Method and system for identifying biomarkers using a probability map
US11583365B2 (en) 2015-10-07 2023-02-21 uLab Systems, Inc. System and methods for tooth movement as a flock
US10357336B2 (en) 2015-10-07 2019-07-23 uLab Systems, Inc. Systems and methods for fabricating dental appliances or shells
US10624717B2 (en) 2015-10-07 2020-04-21 Ulab Systems Inc. Tooth modeling system
US10548690B2 (en) 2015-10-07 2020-02-04 uLab Systems, Inc. Orthodontic planning systems
US10631953B2 (en) 2015-10-07 2020-04-28 uLab Systems, Inc. Three-dimensional printed dental appliances using support structures
US10335250B2 (en) 2015-10-07 2019-07-02 uLab Systems, Inc. Three-dimensional printed dental appliances using lattices
GB201519801D0 (en) * 2015-11-10 2015-12-23 Rolls Royce Plc Pass fail sentencing of hollow components
FR3045156B1 (en) * 2015-12-11 2017-12-22 Soitec Silicon On Insulator FAULT DETECTION METHOD AND DEVICE THEREFOR
US10776963B2 (en) 2016-07-01 2020-09-15 Cubismi, Inc. System and method for forming a super-resolution biomarker map image
US10952821B2 (en) 2016-09-21 2021-03-23 uLab Systems, Inc. Combined orthodontic movement of teeth with temporomandibular joint therapy
US10357342B2 (en) 2016-09-21 2019-07-23 uLab Systems, Inc. Digital dental examination and documentation
WO2018057622A1 (en) 2016-09-21 2018-03-29 uLab Systems, Inc. Combined orthodontic movement of teeth with airway development therapy
CN110573106B (en) 2017-01-12 2023-02-21 马佐尔机器人有限公司 Image-based pathology prediction using artificial intelligence
US11139000B2 (en) * 2017-03-07 2021-10-05 Mediatek Inc. Method and apparatus for signaling spatial region information
US11232853B2 (en) 2017-04-21 2022-01-25 Cubisme, Inc. System and method for creating, querying, and displaying a MIBA master file
SG11202007487UA (en) * 2018-03-02 2020-09-29 Lion Corp Testing method for determining oral indicator
US10721256B2 (en) 2018-05-21 2020-07-21 Oracle International Corporation Anomaly detection based on events composed through unsupervised clustering of log messages
KR101952887B1 (en) * 2018-07-27 2019-06-11 김예현 Method for predicting anatomical landmarks and device for predicting anatomical landmarks using the same
US11178161B2 (en) 2019-04-18 2021-11-16 Oracle International Corporation Detecting anomalies during operation of a computer system based on multimodal data
WO2021030868A1 (en) * 2019-08-20 2021-02-25 HAVApp Pty Ltd A method and a system for determining a likelihood of presence of arthritis in a hand of a patient
US11704796B2 (en) * 2020-01-09 2023-07-18 Ping An Technology (Shenzhen) Co., Ltd. Estimating bone mineral density from plain radiograph by assessing bone texture with deep learning
US11054534B1 (en) 2020-04-24 2021-07-06 Ronald Nutt Time-resolved positron emission tomography encoder system for producing real-time, high resolution, three dimensional positron emission tomographic image without the necessity of performing image reconstruction
US11300695B2 (en) 2020-04-24 2022-04-12 Ronald Nutt Time-resolved positron emission tomography encoder system for producing event-by-event, real-time, high resolution, three-dimensional positron emission tomographic image without the necessity of performing image reconstruction
CA3212928A1 (en) * 2021-04-02 2022-10-06 John Chen Systems and methods to process electronic medical images for diagnostic or interventional use
TWI828096B (en) * 2022-03-25 2024-01-01 英屬開曼群島商百蒂醫股份有限公司 X-ray image analysis method
CN115482914B (en) * 2022-09-14 2023-10-24 湖南提奥医疗科技有限公司 Medical image data processing method, device and storage medium

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5806520A (en) * 1994-03-25 1998-09-15 Centre National De La Recherche Scientifique (C.N.R.S.) Method and device for evaluating and characterizing the properties of bone
US6013031A (en) * 1998-03-09 2000-01-11 Mendlein; John D. Methods and devices for improving ultrasonic measurements using anatomic landmarks and soft tissue correction
US6077224A (en) * 1998-03-23 2000-06-20 Lang; Philipp Methods and device for improving broadband ultrasonic attenuation and speed of sound measurements using anatomical landmarks
US6283997B1 (en) * 1998-11-13 2001-09-04 The Trustees Of Princeton University Controlled architecture ceramic composites by stereolithography
US20020037092A1 (en) * 2000-07-19 2002-03-28 Craig Monique F. Method and system for analyzing animal digit conformation
US20020082779A1 (en) * 2000-10-17 2002-06-27 Maria-Grazia Ascenzi System and method for modeling bone structure
US20020114425A1 (en) * 2000-10-11 2002-08-22 Philipp Lang Methods and devices for analysis of X-ray images
US20020188297A1 (en) * 1998-09-28 2002-12-12 Dakin Edward B. Internal cord fixation device
US20040009459A1 (en) * 2002-05-06 2004-01-15 Anderson James H. Simulation system for medical procedures
US20040106868A1 (en) * 2002-09-16 2004-06-03 Siau-Way Liew Novel imaging markers in musculoskeletal disease
US6775401B2 (en) * 2000-03-29 2004-08-10 The Trustees Of The University Of Pennsylvania Subvoxel processing: a method for reducing partial volume blurring
US20050010106A1 (en) * 2003-03-25 2005-01-13 Imaging Therapeutics, Inc. Methods for the compensation of imaging technique in the processing of radiographic images
US6975894B2 (en) * 2001-04-12 2005-12-13 Trustees Of The University Of Pennsylvania Digital topological analysis of trabecular bone MR images and prediction of osteoporosis fractures
US8818484B2 (en) * 2002-09-16 2014-08-26 Imatx, Inc. Methods of predicting musculoskeletal disease

Family Cites Families (160)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2274808A (en) 1941-01-07 1942-03-03 Irwin C Rinn Bite wing for dental film packs and the like
US7366676B2 (en) 2001-05-29 2008-04-29 Mevis Breastcare Gmbh & Co. Kg Method and system for in-service monitoring and training for a radiologic workstation
DE2042009C3 (en) 1970-08-25 1975-02-27 Siemens Ag, 1000 Berlin U. 8000 Muenchen Arrangement for the non-destructive density measurement of substances of living objects by means of penetrating rays
US4012638A (en) 1976-03-09 1977-03-15 Altschuler Bruce R Dental X-ray alignment system
US4126789A (en) 1977-06-06 1978-11-21 Vogl Thomas M X-ray phantom
US4298800A (en) 1978-02-27 1981-11-03 Computome Corporation Tomographic apparatus and method for obtaining three-dimensional information by radiation scanning
GB2023920A (en) 1978-06-19 1980-01-03 Thoro Ray Inc Dental X-ray apparatus
US4686695A (en) 1979-02-05 1987-08-11 Board Of Trustees Of The Leland Stanford Junior University Scanned x-ray selective imaging system
US4233507A (en) 1979-05-07 1980-11-11 General Electric Company Computer tomography table containing calibration and correlation samples
US4251732A (en) 1979-08-20 1981-02-17 Fried Alan J Dental x-ray film holders
US4356400A (en) 1980-08-04 1982-10-26 General Electric Company X-Ray apparatus alignment method and device
US4400827A (en) 1981-11-13 1983-08-23 Spears James R Method and apparatus for calibrating rapid sequence radiography
FR2547495B1 (en) 1983-06-16 1986-10-24 Mouyen Francis APPARATUS FOR OBTAINING A DENTAL RADIOLOGICAL IMAGE
US4649561A (en) 1983-11-28 1987-03-10 Ben Arnold Test phantom and method of use of same
JPS61109557A (en) * 1984-11-02 1986-05-28 帝人株式会社 Evaluation of bone
US4782502A (en) 1986-10-01 1988-11-01 Schulz Eloy E Flexible calibration phantom for computer tomography system
US4985906A (en) 1987-02-17 1991-01-15 Arnold Ben A Calibration phantom for computer tomography system
CA1288176C (en) 1987-10-29 1991-08-27 David C. Hatcher Method and apparatus for improving the alignment of radiographic images
US4922915A (en) 1987-11-27 1990-05-08 Ben A. Arnold Automated image detail localization method
US5127032A (en) 1987-12-03 1992-06-30 Johns Hopkins University Multi-directional x-ray imager
US4956859A (en) 1989-03-10 1990-09-11 Expert Image Systems, Inc. Source filter for radiographic imaging
US5090040A (en) 1989-03-10 1992-02-18 Expert Image Systems, Inc. Data acquisition system for radiographic imaging
US5001738A (en) 1989-04-07 1991-03-19 Brooks Jack D Dental X-ray film holding tab and alignment method
FR2649883B1 (en) 1989-07-20 1991-10-11 Gen Electric Cgr METHOD FOR CORRECTING THE MEASUREMENT OF BONE DENSITY IN A SCANNER
US5537483A (en) 1989-10-03 1996-07-16 Staplevision, Inc. Automated quality assurance image processing system
US5150394A (en) 1989-12-05 1992-09-22 University Of Massachusetts Medical School Dual-energy system for quantitative radiographic imaging
US6031892A (en) 1989-12-05 2000-02-29 University Of Massachusetts Medical Center System for quantitative radiographic imaging
US5864146A (en) 1996-11-13 1999-01-26 University Of Massachusetts Medical Center System for quantitative radiographic imaging
US5562448A (en) 1990-04-10 1996-10-08 Mushabac; David R. Method for facilitating dental diagnosis and treatment
US5122664A (en) 1990-04-27 1992-06-16 Fuji Photo Film Co., Ltd. Method and apparatus for quantitatively analyzing bone calcium
US5228445A (en) * 1990-06-18 1993-07-20 Board Of Regents, The University Of Texas System Demonstration by in vivo measurement of reflection ultrasound analysis of improved bone quality following slow-release fluoride treatment in osteoporosis patients
US5172695A (en) 1990-09-10 1992-12-22 Cann Christopher E Method for improved prediction of bone fracture risk using bone mineral density in structural analysis
DE9016046U1 (en) 1990-11-26 1991-02-14 Kalender, Willi, Dr., 8521 Kleinseebach, De
US5533084A (en) 1991-02-13 1996-07-02 Lunar Corporation Bone densitometer with improved vertebral characterization
US5577089A (en) * 1991-02-13 1996-11-19 Lunar Corporation Device and method for analysis of bone morphology
JP2641078B2 (en) 1991-03-28 1997-08-13 富士写真フイルム株式会社 Bone mineral analysis
US5200993A (en) 1991-05-10 1993-04-06 Bell Atlantic Network Services, Inc. Public telephone network including a distributed imaging system
US5270651A (en) * 1991-05-21 1993-12-14 The Trustees Of The University Of Pennsylvania Method and apparatus for diagnosing osteoporosis
US5247934A (en) * 1991-08-09 1993-09-28 Trustees Of The University Of Pennsylvania Method and apparatus for diagnosing osteoporosis with MR imaging
US5271401A (en) 1992-01-15 1993-12-21 Praxair Technology, Inc. Radiological imaging method
DE69329168T2 (en) 1992-05-20 2001-04-05 Aloka Co Ltd Device for determining the properties of bones
US5521955A (en) 1992-05-29 1996-05-28 Ge Yokogawa Medical Systems, Limited Method for quantitatively determining bone mineral mass by CT system
US5321520A (en) 1992-07-20 1994-06-14 Automated Medical Access Corporation Automated high definition/resolution image storage, retrieval and transmission system
US5281232A (en) 1992-10-13 1994-01-25 Board Of Regents Of The University Of Arizona/ University Of Arizona Reference frame for stereotactic radiosurgery using skeletal fixation
US5320102A (en) * 1992-11-18 1994-06-14 Ciba-Geigy Corporation Method for diagnosing proteoglycan deficiency in cartilage based on magnetic resonance image (MRI)
US5335260A (en) 1992-11-25 1994-08-02 Arnold Ben A Calibration phantom and improved method of quantifying calcium and bone density using same
US5592943A (en) 1993-04-07 1997-01-14 Osteo Sciences Corporation Apparatus and method for acoustic analysis of bone using optimized functions of spectral and temporal signal components
US5513240A (en) 1993-05-18 1996-04-30 The Research Foundation Of Suny Intraoral radiograph alignment device
FR2705785B1 (en) 1993-05-28 1995-08-25 Schlumberger Ind Sa Method for determining the attenuation function of an object with respect to the transmission of a reference thickness of a reference material and device for implementing the method.
US5657369A (en) 1993-11-22 1997-08-12 Hologic, Inc. X-ray bone densitometry system having forearm positioning assembly
US5931780A (en) 1993-11-29 1999-08-03 Arch Development Corporation Method and system for the computerized radiographic analysis of bone
EP0660599B2 (en) 1993-12-24 2002-08-14 Agfa-Gevaert Partially-transparent-shield-method for scattered radiation compensation in x-ray imaging
US5948692A (en) 1994-02-19 1999-09-07 Seikagaku Corporation Method and measurement kit for assay of normal agrecan, and method for evaluation of informations on the joint
US5600574A (en) 1994-05-13 1997-02-04 Minnesota Mining And Manufacturing Company Automated image quality control
US5476865A (en) 1994-07-06 1995-12-19 Eli Lilly And Company Methods of inhibiting bone loss
US5915036A (en) * 1994-08-29 1999-06-22 Eskofot A/S Method of estimation
US5493593A (en) 1994-09-27 1996-02-20 University Of Delaware Tilted detector microscopy in computerized tomography
WO1996012187A1 (en) 1994-10-13 1996-04-25 Horus Therapeutics, Inc. Computer assisted methods for diagnosing diseases
SE9601065L (en) 1996-03-20 1997-03-03 Siemens Elema Ab Anesthesia System
US5594775A (en) 1995-04-19 1997-01-14 Wright State University Method and apparatus for the evaluation of cortical bone by computer tomography
US5886353A (en) 1995-04-21 1999-03-23 Thermotrex Corporation Imaging device
US5565678A (en) 1995-06-06 1996-10-15 Lumisys, Inc. Radiographic image quality assessment utilizing a stepped calibration target
US5772592A (en) 1996-01-08 1998-06-30 Cheng; Shu Lin Method for diagnosing and monitoring osteoporosis
US6215846B1 (en) 1996-02-21 2001-04-10 Lunar Corporation Densitometry adapter for compact x-ray fluoroscopy machine
US5785041A (en) 1996-03-26 1998-07-28 Hologic Inc. System for assessing bone characteristics
EP0898766A1 (en) 1996-05-06 1999-03-03 Torsana Osteoporosis Diagnostics A/S A method of estimating skeletal status
US6108635A (en) 1996-05-22 2000-08-22 Interleukin Genetics, Inc. Integrated disease information system
US5837674A (en) * 1996-07-03 1998-11-17 Big Bear Bio, Inc. Phosphopeptides and methods of treating bone diseases
US5919808A (en) * 1996-10-23 1999-07-06 Zymogenetics, Inc. Compositions and methods for treating bone deficit conditions
US5945412A (en) 1996-12-09 1999-08-31 Merck & Co., Inc. Methods and compositions for preventing and treating bone loss
US8545569B2 (en) * 2001-05-25 2013-10-01 Conformis, Inc. Patient selectable knee arthroplasty devices
GB9702202D0 (en) 1997-02-04 1997-03-26 Osteometer Meditech As Diagnosis of arthritic conditions
AU8103198A (en) 1997-07-04 1999-01-25 Torsana Osteoporosis Diagnostics A/S A method for estimating the bone quality or skeletal status of a vertebrate
AU766783B2 (en) 1997-08-19 2003-10-23 Philipp Lang Ultrasonic transmission films and devices, particularly for hygienic transducer surfaces
US5917877A (en) 1997-09-05 1999-06-29 Cyberlogic, Inc. Plain x-ray bone densitometry apparatus and method
US6064716A (en) 1997-09-05 2000-05-16 Cyberlogic, Inc. Plain x-ray bone densitometry apparatus and method
IL134760A0 (en) 1997-09-09 2001-04-30 Procter & Gamble Method of increasing bone volume using non-naturally-occurring fp selective agonists
US5852647A (en) 1997-09-24 1998-12-22 Schick Technologies Method and apparatus for measuring bone density
JP3656695B2 (en) 1997-09-30 2005-06-08 富士写真フイルム株式会社 Bone measuring method and apparatus
US6252928B1 (en) 1998-01-23 2001-06-26 Guard Inc. Method and device for estimating bone mineral content of the calcaneus
JPH11239165A (en) 1998-02-20 1999-08-31 Fuji Photo Film Co Ltd Medical network system
US6320931B1 (en) 1998-03-02 2001-11-20 Image Analysis, Inc. Automated x-ray bone densitometer
EP1061854A4 (en) 1998-03-09 2005-07-13 Philipp Lang Methods and devices for improving broadband ultrasonic attenuation and speed of sound measurements
EP0952726B1 (en) 1998-04-24 2003-06-25 Eastman Kodak Company Method and system for associating exposed radiographic films with proper patient information
US6835377B2 (en) 1998-05-13 2004-12-28 Osiris Therapeutics, Inc. Osteoarthritis cartilage regeneration
US6442287B1 (en) * 1998-08-28 2002-08-27 Arch Development Corporation Method and system for the computerized analysis of bone mass and structure
JP3639750B2 (en) 1998-08-31 2005-04-20 キヤノン株式会社 Image acquisition device
US6714623B2 (en) 1998-08-31 2004-03-30 Canon Kabushiki Kaisha Image collecting system
ATE439806T1 (en) 1998-09-14 2009-09-15 Univ Leland Stanford Junior DETERMINING THE CONDITION OF A JOINT AND PREVENTING DAMAGE
US7239908B1 (en) 1998-09-14 2007-07-03 The Board Of Trustees Of The Leland Stanford Junior University Assessing the condition of a joint and devising treatment
US7184814B2 (en) 1998-09-14 2007-02-27 The Board Of Trustees Of The Leland Stanford Junior University Assessing the condition of a joint and assessing cartilage loss
US6501827B1 (en) 1998-09-29 2002-12-31 Canon Kabushiki Kaisha Examination system, image processing apparatus and method, medium, and x-ray photographic system
JP3499761B2 (en) 1998-10-22 2004-02-23 帝人株式会社 Bone image processing method and bone strength evaluation method
DE19853965A1 (en) 1998-11-23 2000-05-31 Siemens Ag Bone contour and bone structure determination
US7283857B1 (en) 1998-11-30 2007-10-16 Hologic, Inc. DICOM compliant file communication including quantitative and image data
US6302582B1 (en) 1998-12-22 2001-10-16 Bio-Imaging Technologies, Inc. Spine phantom simulating cortical and trabecular bone for calibration of dual energy x-ray bone densitometers
US6430427B1 (en) 1999-02-25 2002-08-06 Electronics And Telecommunications Research Institute Method for obtaining trabecular index using trabecular pattern and method for estimating bone mineral density using trabecular indices
JP4067220B2 (en) 1999-03-25 2008-03-26 富士フイルム株式会社 Quality control system for medical diagnostic equipment
US6178225B1 (en) 1999-06-04 2001-01-23 Edge Medical Devices Ltd. System and method for management of X-ray imaging facilities
US6356621B1 (en) 1999-07-14 2002-03-12 Nitto Denko Corporation Pressure-sensitive adhesive sheet for radiography
US6694047B1 (en) 1999-07-15 2004-02-17 General Electric Company Method and apparatus for automated image quality evaluation of X-ray systems using any of multiple phantoms
US6285901B1 (en) 1999-08-25 2001-09-04 Echo Medical Systems, L.L.C. Quantitative magnetic resonance method and apparatus for bone analysis
US6490476B1 (en) * 1999-10-14 2002-12-03 Cti Pet Systems, Inc. Combined PET and X-ray CT tomograph and method for using same
US6246745B1 (en) * 1999-10-29 2001-06-12 Compumed, Inc. Method and apparatus for determining bone mineral density
US6605591B1 (en) * 1999-11-12 2003-08-12 Genelabs Technologies, Inc. Treatment of subnormal bone mineral density
US6219674B1 (en) 1999-11-24 2001-04-17 Classen Immunotherapies, Inc. System for creating and managing proprietary product data
US6315553B1 (en) 1999-11-30 2001-11-13 Orametrix, Inc. Method and apparatus for site treatment of an orthodontic patient
FR2801776B1 (en) 1999-12-03 2002-04-26 Commissariat Energie Atomique METHOD OF USING AN OSTEODENSITOMETRY SYSTEM, BY BI-ENERGY X-RADIATION, WITH A CONICAL BEAM
KR100343777B1 (en) 1999-12-10 2002-07-20 한국전자통신연구원 Method for calibrating trabecular index using sawtooth-shaped rack
US6463344B1 (en) 2000-02-17 2002-10-08 Align Technology, Inc. Efficient data representation of teeth model
JP2002045722A (en) 2000-08-03 2002-02-12 Inax Corp Garbage crusher
US6249692B1 (en) 2000-08-17 2001-06-19 The Research Foundation Of City University Of New York Method for diagnosis and management of osteoporosis
WO2002017210A2 (en) 2000-08-18 2002-02-28 Cygnus, Inc. Formulation and manipulation of databases of analyte and associated values
US6904123B2 (en) 2000-08-29 2005-06-07 Imaging Therapeutics, Inc. Methods and devices for quantitative analysis of x-ray images
US20020186818A1 (en) 2000-08-29 2002-12-12 Osteonet, Inc. System and method for building and manipulating a centralized measurement value database
JP4049312B2 (en) 2000-08-29 2008-02-20 イメージング セラピューティクス,インコーポレーテッド X-ray image quantitative analysis method and apparatus
US7050534B2 (en) 2000-08-29 2006-05-23 Imaging Therapeutics, Inc. Methods and devices for quantitative analysis of x-ray images
US7467892B2 (en) 2000-08-29 2008-12-23 Imaging Therapeutics, Inc. Calibration devices and methods of use thereof
ATE426357T1 (en) 2000-09-14 2009-04-15 Univ Leland Stanford Junior ASSESSING THE CONDITION OF A JOINT AND PLANNING TREATMENT
US6799066B2 (en) 2000-09-14 2004-09-28 The Board Of Trustees Of The Leland Stanford Junior University Technique for manipulating medical images
US8639009B2 (en) 2000-10-11 2014-01-28 Imatx, Inc. Methods and devices for evaluating and treating a bone condition based on x-ray image analysis
US20070047794A1 (en) 2000-10-11 2007-03-01 Philipp Lang Methods and devices for analysis of x-ray images
US7660453B2 (en) 2000-10-11 2010-02-09 Imaging Therapeutics, Inc. Methods and devices for analysis of x-ray images
CA2427483C (en) * 2000-10-31 2011-07-26 Ecole De Technologie Superieure High precision modeling of a body part using a 3d imaging system
DE20100641U1 (en) 2001-01-27 2001-07-26 Steer Sebastian Universally adjustable holder system for easy positioning of a recording medium for X-rays
FR2820966B1 (en) 2001-02-16 2003-04-04 Commissariat Energie Atomique DOUBLE ENERGY RADIOGRAPHY METHOD, AND CALIBRATION DEVICE THEREFOR
US20050037515A1 (en) * 2001-04-23 2005-02-17 Nicholson Jeremy Kirk Methods for analysis of spectral data and their applications osteoporosis
US6829378B2 (en) 2001-05-04 2004-12-07 Biomec, Inc. Remote medical image analysis
US8000766B2 (en) 2001-05-25 2011-08-16 Imatx, Inc. Methods to diagnose treat and prevent bone loss
US20040247074A1 (en) 2001-10-17 2004-12-09 Langton Christian M. Bone simulation analysis
US6895077B2 (en) 2001-11-21 2005-05-17 University Of Massachusetts Medical Center System and method for x-ray fluoroscopic imaging
AU2002360293A1 (en) 2001-11-23 2003-06-10 The University Of Chicago Differentiation of bone disease on radiographic images
EP1666883A1 (en) 2002-02-08 2006-06-07 F. Hoffmann-La Roche AG Diagnostic and monitoring methods for bone loss
JP3799603B2 (en) 2002-02-13 2006-07-19 勇 鹿島 Trabecular structure analysis method and trabecular structure improvement effect judgment support method
EP1349098B1 (en) 2002-03-27 2008-05-28 Agfa HealthCare NV Method of performing geometric measurements on digital radiological images using graphical templates
EP1357480A1 (en) 2002-04-17 2003-10-29 Agfa-Gevaert Osteoporosis screening method
US20030198316A1 (en) 2002-04-17 2003-10-23 Piet Dewaele Osteoporosis screening method
US7574248B2 (en) 2002-05-17 2009-08-11 General Hospital Corporation Method and apparatus for quantitative bone matrix imaging by magnetic resonance imaging
KR100442503B1 (en) 2002-05-18 2004-07-30 엘지.필립스 엘시디 주식회사 Image quality analysis method and system for display device by using the fractal dimension
WO2004001569A2 (en) 2002-06-21 2003-12-31 Cedara Software Corp. Computer assisted system and method for minimal invasive hip, uni knee and total knee replacement
US8965075B2 (en) 2002-09-16 2015-02-24 Imatx, Inc. System and method for predicting future fractures
US6836557B2 (en) 2002-10-02 2004-12-28 VirtualS{tilde over (c)}opics, LLC Method and system for assessment of biomarkers by measurement of response to stimulus
US20040101186A1 (en) 2002-11-27 2004-05-27 Xin Tong Initializing model-based interpretations of digital radiographs
US7769214B2 (en) 2002-12-05 2010-08-03 The Trustees Of The University Of Pennsylvania Method for measuring structural thickness from low-resolution digital images
US7848558B2 (en) 2003-02-14 2010-12-07 The University Of Chicago Method and system for fractal-based analysis of medical image texture
US7092749B2 (en) 2003-06-11 2006-08-15 Siemens Medical Solutions Usa, Inc. System and method for adapting the behavior of a diagnostic medical ultrasound system based on anatomic features present in ultrasound images
US20050015002A1 (en) 2003-07-18 2005-01-20 Dixon Gary S. Integrated protocol for diagnosis, treatment, and prevention of bone mass degradation
US20050059887A1 (en) * 2003-09-16 2005-03-17 Hassan Mostafavi Localization of a target using in vivo markers
US8290564B2 (en) 2003-09-19 2012-10-16 Imatx, Inc. Method for bone structure prognosis and simulated bone remodeling
AU2004274003A1 (en) 2003-09-19 2005-03-31 Imaging Therapeutics, Inc. Method for bone structure prognosis and simulated bone remodeling
GB0325523D0 (en) 2003-10-31 2003-12-03 Univ Aberdeen Apparatus for predicting bone fracture risk
EP1598778B1 (en) 2004-05-18 2008-08-13 Agfa HealthCare NV Method for automatically mapping of geometric objects in digital medical images
CA2580726A1 (en) 2004-09-16 2006-03-30 Imaging Therapeutics, Inc. System and method of predicting future fractures
JP5116947B2 (en) 2005-03-02 2013-01-09 株式会社沖データ Transfer device and image forming apparatus
US20070156066A1 (en) * 2006-01-03 2007-07-05 Zimmer Technology, Inc. Device for determining the shape of an anatomic surface
WO2008034101A2 (en) 2006-09-15 2008-03-20 Imaging Therapeutics, Inc. Method and system for providing fracture/no fracture classification
US8377016B2 (en) 2007-01-10 2013-02-19 Wake Forest University Health Sciences Apparatus and method for wound treatment employing periodic sub-atmospheric pressure
US8617175B2 (en) 2008-12-16 2013-12-31 Otismed Corporation Unicompartmental customized arthroplasty cutting jigs and methods of making the same
US8939917B2 (en) 2009-02-13 2015-01-27 Imatx, Inc. Methods and devices for quantitative analysis of bone and cartilage
US9330490B2 (en) 2011-04-29 2016-05-03 University Health Network Methods and systems for visualization of 3D parametric data during 2D imaging

Patent Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5806520A (en) * 1994-03-25 1998-09-15 Centre National De La Recherche Scientifique (C.N.R.S.) Method and device for evaluating and characterizing the properties of bone
US6013031A (en) * 1998-03-09 2000-01-11 Mendlein; John D. Methods and devices for improving ultrasonic measurements using anatomic landmarks and soft tissue correction
US6077224A (en) * 1998-03-23 2000-06-20 Lang; Philipp Methods and device for improving broadband ultrasonic attenuation and speed of sound measurements using anatomical landmarks
US20020188297A1 (en) * 1998-09-28 2002-12-12 Dakin Edward B. Internal cord fixation device
US6283997B1 (en) * 1998-11-13 2001-09-04 The Trustees Of Princeton University Controlled architecture ceramic composites by stereolithography
US6775401B2 (en) * 2000-03-29 2004-08-10 The Trustees Of The University Of Pennsylvania Subvoxel processing: a method for reducing partial volume blurring
US20020037092A1 (en) * 2000-07-19 2002-03-28 Craig Monique F. Method and system for analyzing animal digit conformation
US7088847B2 (en) * 2000-07-19 2006-08-08 Craig Monique F Method and system for analyzing animal digit conformation
US20020114425A1 (en) * 2000-10-11 2002-08-22 Philipp Lang Methods and devices for analysis of X-ray images
US20020082779A1 (en) * 2000-10-17 2002-06-27 Maria-Grazia Ascenzi System and method for modeling bone structure
US6975894B2 (en) * 2001-04-12 2005-12-13 Trustees Of The University Of Pennsylvania Digital topological analysis of trabecular bone MR images and prediction of osteoporosis fractures
US20040009459A1 (en) * 2002-05-06 2004-01-15 Anderson James H. Simulation system for medical procedures
US20040106868A1 (en) * 2002-09-16 2004-06-03 Siau-Way Liew Novel imaging markers in musculoskeletal disease
US8818484B2 (en) * 2002-09-16 2014-08-26 Imatx, Inc. Methods of predicting musculoskeletal disease
US20050010106A1 (en) * 2003-03-25 2005-01-13 Imaging Therapeutics, Inc. Methods for the compensation of imaging technique in the processing of radiographic images

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9767551B2 (en) 2000-10-11 2017-09-19 Imatx, Inc. Methods and devices for analysis of x-ray images
US9275469B2 (en) 2000-10-11 2016-03-01 Imatx, Inc. Methods and devices for evaluating and treating a bone condition on x-ray image analysis
US9267955B2 (en) 2001-05-25 2016-02-23 Imatx, Inc. Methods to diagnose treat and prevent bone loss
US9460506B2 (en) 2002-09-16 2016-10-04 Imatx, Inc. System and method for predicting future fractures
US9155501B2 (en) 2003-03-25 2015-10-13 Imatx, Inc. Methods for the compensation of imaging technique in the processing of radiographic images
US9737406B2 (en) 2013-08-21 2017-08-22 Laboratories Bodycad Inc. Anatomically adapted orthopedic implant and method of manufacturing same
US10667829B2 (en) 2013-08-21 2020-06-02 Laboratoires Bodycad Inc. Bone resection guide and method
US11583298B2 (en) 2013-08-21 2023-02-21 Laboratoires Bodycad Inc. Bone resection guide and method
US20170098315A1 (en) * 2015-10-06 2017-04-06 Rigaku Corporation Analyzer, analysis method and analysis program of bone mineral density
US9940737B2 (en) * 2015-10-06 2018-04-10 Rigaku Corporation Analyzer, analysis method and analysis program of bone mineral density
USD808524S1 (en) 2016-11-29 2018-01-23 Laboratoires Bodycad Inc. Femoral implant
WO2018204404A1 (en) * 2017-05-01 2018-11-08 Rhode Island Hospital Non-invasive measurement to predict post-surgery anterior cruciate ligament success
US11234657B2 (en) 2017-05-01 2022-02-01 Rhode Island Hospital Non-invasive measurement to predict post-surgery anterior cruciate ligament success
US20200170604A1 (en) * 2018-12-04 2020-06-04 Howmedica Osteonics Corp. CT Based Probabilistic Cancerous Bone Region Detection

Also Published As

Publication number Publication date
US20110105885A1 (en) 2011-05-05
US8818484B2 (en) 2014-08-26
US20040242987A1 (en) 2004-12-02
US20190370961A1 (en) 2019-12-05
US7840247B2 (en) 2010-11-23
US20180330499A1 (en) 2018-11-15

Similar Documents

Publication Publication Date Title
US20190370961A1 (en) Methods of Predicting Musculoskeletal Disease
US8965087B2 (en) System and method of predicting future fractures
US9460506B2 (en) System and method for predicting future fractures
EP1583467B1 (en) Device for predicting musculoskeletal disease
US20040106868A1 (en) Novel imaging markers in musculoskeletal disease
US9155501B2 (en) Methods for the compensation of imaging technique in the processing of radiographic images
US8290564B2 (en) Method for bone structure prognosis and simulated bone remodeling
US8073521B2 (en) Method for bone structure prognosis and simulated bone remodeling

Legal Events

Date Code Title Description
AS Assignment

Owner name: IMAGING THERAPEUTICS, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LIEW, SIAU-WAY;STEINES, DANIEL;LANG, PHILIPP;SIGNING DATES FROM 20040611 TO 20040702;REEL/FRAME:043308/0702

Owner name: IMATX, INC., MASSACHUSETTS

Free format text: MERGER AND CHANGE OF NAME;ASSIGNORS:IMAGING THERAPEUTICS, INC.;IMATX, INC.;REEL/FRAME:043308/0885

Effective date: 20091230

Owner name: IMATX, INC., MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VARGAS-VORACEK, RENE;REEL/FRAME:043308/0938

Effective date: 20120202

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COL

Free format text: SECURITY INTEREST;ASSIGNORS:CONFORMIS, INC.;IMATX, INC.;CONFORMIS CARES LLC;REEL/FRAME:049588/0288

Effective date: 20190625

Owner name: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT, NEW YORK

Free format text: SECURITY INTEREST;ASSIGNORS:CONFORMIS, INC.;IMATX, INC.;CONFORMIS CARES LLC;REEL/FRAME:049588/0288

Effective date: 20190625

AS Assignment

Owner name: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, NEW YORK

Free format text: RELEASE BY SECURED PARTY;ASSIGNORS:CONFORMIS, INC.;IMATX, INC.;CONFORMIS CARES LLC;REEL/FRAME:058234/0292

Effective date: 20211122